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ABSTRACT

CHARACTERIZATION OF CYCLIC-DI-GMP SIGNALING WITHIN THE LYME
SPIROCHETE, BORRELIA BURGDORFERI
By Jessica L. Kostick, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2011
Major Director: Richard T. Marconi, Ph.D.
Professor, Department of Microbiology and Immunology

Lyme disease is a tick-borne infection caused by Borrelia burgdorferi, B. garinii,
and B. afzelii. These spirochetes experience environmental fluctuations as they are
passed between mammalian and Ixodes tick hosts throughout their enzootic cycle.
Recent studies have suggested cyclic diguanylate (c-di-GMP), a ubiquitous secondary
messenger, is a key modulator of B. burgdorferi adaptive responses and may play a
significant role in cycle progression. In this study, we examined the impact of the sole
diguanylate cyclase (Rrp1), c-di-GMP binding proteins (PlzA and PlzB), and HD-GYPcontaining phosphodiesterase (PdeB) in disease establishment of both murine and
Ixodes tick systems. Strains harboring targeted gene deletions or plasmid-based
constitutive gene expression constructs were generated.
xiv

Rrp1 was required for tick colonization, yet overexpression abolished murine
disease, thus implicating the requirement of finely regulated c-di-GMP levels for
enzootic cycle progression. Deletion of rrp1 disrupted translational motion and
swarming patterns by causing extended cell runs, eliminating stops/flexes, and reducing
swarming capabilities. This was attributed to a defect in N-acetyl-D-glucosamine (NAG)
metabolism and chemotaxis. NAG is a major source of nutrition for B. burgdorferi within
the tick environment; therefore this defect would impede spirochete migration towards
feeding ticks, as well as pathogen uptake and survival within the Ixodes vector.
In contrast, the downstream c-di-GMP effector, PlzA, was critical for murine
disease but nonessential for survival within ticks nor functionally complemented by
PlzB. Deletion of plzA altered strain motility and swarming similarly to the rrp1 deletion
mutant, yet had a distinct phenotype with significantly slower translational motion and
no affect on NAG chemotaxis and metabolism. This indicates B. burgdorferi could
possess alternate c-di-GMP effectors or Rrp1 could be directly influencing these cellular
processes.
Uniquely, PdeB did not abolish murine infection via needle inoculation, but was
required for natural transmission from ticks. This defect was linked to the decreased
tick colonization efficiency upon pdeB deletion.
Together, these analyses indicate that c-di-GMP signaling is an important
virulence mechanism of Borrelia burgdorferi and demonstrate the complexity of this
signaling pathway in an arthropod-borne pathogen. The data presented here
additionally provide significant new insight into the gene regulatory mechanisms of the
Lyme disease spirochetes.
xv

CHAPTER 1: INTRODUCTION & OVERVIEW

Lyme disease is an important emerging infection that plagues multiple continents
throughout the world. Currently, it is the most common arthropod-borne illness in North
America and Europe, but cases have also been reported in Asia (32). According to the
Centers for Disease Control (CDC), this infection was named the 6th most common
national notifiable disease in 2008 and the incidence continues to grow at a rapid pace.
Approximately 39,000 cases were reported nationally in 2009, yet this estimate is
believed to be an underrepresentation of the true number of cases due to misdiagnosis
and lack of reporting (108). A United States incidence map schematic is depicted in
Figure 1-1. Connecticut is the epicentre for contraction of Lyme disease but, as
reported by the CDC, ninety-five percent of the total cases typically arise from twelve
key states including: Connecticut, Delaware, Maine, Maryland, Massachusetts,
Minnesota, New Hampshire, New Jersey, New York, Pennsylvania, Virginia, and
Wisconsin.
The disease was first recognized in 1976 when juvenile rheumatoid arthritis
symptoms plagued adolescent residents of the small town Lyme, Connecticut (92). It
later became apparent that the symptoms were merely a late stage manifestation of a
multi-system disorder initiated by a tick-transmitted disease (90). However, the cause
of infection remained elusive until 1981, when Dr. Willy Burgdorfer and colleagues
discovered spirochetes within Ixodes tick midguts isolated from Shelter Island, NY (13).
1
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Figure 1-1. 2009 United States Lyme incidence map. Each dot represents a reported
case of Lyme disease and is placed within the patient’s county of residence. As evident by
the dense clustering, Lyme disease is the most prevalent within the Northeastern United
States and the Minnesota/Wisconsin region.
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Ticks samples were cultured in media intended for the growth of relapsing fever
spirochetes, but to the investigators’ surprise, a new species of Borrelia appeared in the
samples. The species, designated Borrelia burgdorferi, was thereafter identified in
Lyme disease patient samples and concluded to be the disease-causing pathogen
(10,13,91). Many patient symptoms, world-wide, were wrongfully misdiagnosed and
symptoms ascribed to unknown viruses, etc. Therefore, this discovery represented a
breakthrough in modern infectious disease medicine.
Many species related to B. burgdorferi have been identified to cause Borreliosislike symptoms, including B. garinii and B. afzelii, which are broadly termed B.
burgdorferi sensu lato (5). The main causative agent within the United States is the
species B. burgdorferi specifically, which is referred to as B. burgdorferi sensu stricto.
Acquisition of this pathogen occurs by the bite of an infected Ixodes tick, then
spirochetes disseminate laterally through host tissues (72,90). Acute symptoms include
the characteristic erythema migrans rash (EM) followed by fever, headache, arthralgia,
and myalgia (88). Early treatment with oral antibiotics such as doxycycline, amoxicillin,
or cefuroxime axetil is extremely effective and patients typically recover quickly and
completely. Without antibiotics, the infection persists and disseminates into chronic
stage Lyme disease with severe neurological, rheumatological, and dermatological
complications such as Borrelial lymphocytoma, Bell’s palsy, and Acrodermatitis chronica
atrophicans (88). According to the CDC, prevention is solely based upon avoidance of
tick habitat, wearing protective clothing, and early detection of symptoms followed by
antibiotic administration. The lack of a commercially available vaccine, incidence climb,
and low rate of prevention with current techniques demonstrate that more aggressive
3

methods of prevention and control are essential to combat the significant health risk
imposed by Lyme disease. Complete analysis of the molecular mechanisms involved in
the Borrelia enzootic cycle is a critical step to understanding and limiting infection.

The enzootic cycle of Borrelia burgdorferi
The Lyme species of Borrelia are maintained within an enzootic cycle consisting
of ticks from the Ixodes ricinus complex and a wide range of animal hosts (Table 1-1)
(52,90). The cycles for each of the respective species has evolved to be location
specific based upon host and tick availability (45). The most notable tick vectors of the
three main pathogenic Lyme species are I. scapularis (deer tick, northeastern and north
central US), I. pacificus (western US), I. ricinus (sheep tick, Europe), and I. persulcatus
(taiga tick, Asia) (90). Interestingly, Lyme disease is most prevalent in the Northeastern
and North central United States where Borrelia burgdorferi is very efficiently transmitted
between I. scapularis ticks and mammals, specifically the white-footed mouse,
chipmunks, and white-tailed deer (51). This trend is not seen in the western portion of
the nation where I. spinipalpis ticks do not bite humans and I. pacificus ticks are less
often infected (12,83). Humans are also inefficiently infected in the southeastern US
due to the I. scapularis ticks feeding readily on lizards which are resistant to infection by
complement-mediated killing of the pathogen (43). As a result, research targeting the
pathogenesis of B. burgdorferi is aimed at understanding the enzootic cycle consisting
of I. scapularis ticks and mammals, which is most often associated with human disease
in the United States.
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Table 1-1. Putative and named Lyme spirochetes.
Species (c/p)a (type strain)

Distribution

B. afzelii (c) (VS461)

Europe, Asia

B. americana (p) (SCW-41)
B. andersonii (c) (21038)

North America
North America
Europe,
Asia (?)

Host range
Apodemus spp.,
Myodes glareolus, Sorex spp.,
Sciurus spp.,
Erinaceus spp.,
Rattus spp.
Thryothorus
ludovicianus,
Pipilo erythrophthalmus
Sylvilagus spp., (Passeriformes spp.)

Main vector
Ixodes ricinus,
I. persulcatus,
I. hexagonus

I. pacificus,
I. minor

I. dentatus
I. ricinus,
I. persulcatus(?)
B. bavariensis (p) (PBi)
Apodemus spp., Myodes sp., Microtus spp.
Neotoma spp., Peromyscus spp., Sigmodon spp.
I. pacificus,
I. spinipalpis,
EU: unknown
I. affinis,
EU: unknown
B. bissettii (c) (DN127-cl9-2)
North America, Europe
Peromyscus spp.,
I. ricinus,
Tamias spp., Neatoma spp., Sorex spp.,
I. hexagonus, I. scapularis,
Sciurus spp., Sigmodon spp.
I. pacificus,
Erinaceus spp., Rattus spp., Procyon lotor, Turdus migratorius, I. affinis,
I. minor,
I. spinipalpis,
B. burgdorferi (c) (B31)
North America, Europe
I. muris
B. californiensis (c) (CA446)
Western US
Dipodomys californensis
Unknown
P. gossypinus,
Unknown
(I. minor?)
B. carolinensis (c) (SCW-22)
Southeast US
N. floridana
I. ricinus,
Turdus merula,
I. persulcatus,
T. philomelos,
B. garinii (c) (20047)
Europe, Asia, Artic-Antartic circles Parus major, seabirds (Puffin, Guillemot, Kittiwake, Razorbill)
I. uriae
Sorex unguiculatus, Apodemus spp.,
B. japonica (c) (HO14)
Japan
Eothenomys smithi
I. ovatus
Unknown
(I. scapularis?)
B. kurtenbachii (p) (25015)
Northamerica, (Europe?)
Microtus pennsylvanicus , Zapus hudsonius Peromyscus?
B. lusitaniae (c) (PoTiB2)
Mediterranean basin
Lacertidae
I. ricinus
B. sinica (c) (CMN3)
China
Niviventer confucianus
I. ovatus
Glis glis,
B. spielmanii (c) (PC-Eq17N5) Europe
Eliomus quercinus
I. ricinus
B. tanukii (c) (Hk501)
Apodemus sp., Clethrionomys rufocanus, Eothenomys smithii I. tanuki
Japan
B. turdi (c) (Ya501)
Turdus spp.
Japan
I. turdus
Turdus merula,
I. ricinus,
T. philomelos,
I. columnae
Parus major
B. valaisiana (c) (VS116)
Europe, Japan
Niviventer fulvescens,
Apodemus sp.
B. yangtze (c) (nd)
China
I. granulatus, I. nipponensis
I. spinipalpis,
Genomospecies2
United States
Unknown
I. pacificus
a
c – confirmed; p – proposed; nd = not determined.

Table adapted from Margos, G., et al. Infection, Genetics, and Evolution. 2011.
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The spirochetes are transmitted between hosts at multiple time points throughout
the two year cycle (Figure 1-2) (51,90). Eggs are laid by adult female ticks in the early
spring and hatched by summer for the larval stage feeding on small mammals and deer,
followed by an autumn molt into nymphs and a dormancy period until spring. In the
second year, the nymphal ticks feed on small mammals, birds, and humans in the late
spring which initiates the final molt into adults by summer. In fall or the next spring, the
adults feed on large mammals (particularly deer), mate, and lay eggs to complete the
cycle.
During host transmission and spirochete acquisition, the bacteria are exposed to
a diverse set of environmental cues (8,12,30,39,89). The pathogen possesses a
minimalist genome consisting of a 0.91Mb linear chromosome which contains a
relatively small set of housekeeping genes and only a few biosynthesis and metabolism
open reading frames (26). As a result, B. burgdorferi is dependent on the rich host
environments to provide nutrients for survival and, as a consequence, alter their gene
expression profiles in accordance to host conditions (80). The Borrelia transcriptome is
responsive to temperatures experienced in the tick (25º) and mammal (37º) along with
alterations in pH, immune pressure, nutrient availability, etc (11,15,24,5961,68).
Typically, bacteria utilize a variety of signalling and transducing mechanisms to respond
to external stimuli, however Borrelia systems remain relatively uncharacterized.

Two-component systems and cellular signalling.
A prominent mechanism of bacterial adaptive responses is the two-component
regulatory system (TCS). These regulators can have global or targeted effects
6
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Figure 1-2. Borrelia burgdorferi enzootic cycle. The pathogen exists in a two year
cycle involving the passage between a variety of hosts. Spirochete acquisition and
transmission occurs through the bite of an infected Ixodes tick.
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(16,70,105). Typically, TCS consist of a histidine kinase and a response regulator (94).
The external stimuli are sensed through the N-terminal sensing domain of the histidine
kinase to cause activation and ATP-dependent phosphorylation of the C-terminal
cytoplasmic transmitter domain (106). The phosphoryl group of the transmitter domain
is then transferred to the receiver domain of the response regulator. Upon transfer, the
response regulator dimerizes and activates its output domain. Output domains can
have a diverse range of functions including DNA-binding, RNA-binding, protein-binding,
or enzymatic functions (29,48,85). Most bacteria contain numerous TCS such as Vibrio
cholera, which alone encodes more than twenty-five (29). Genomic analysis of B.
burgdorferi B31MI revealed approximately five TCS with only two holding global
regulatory potential (70,107). The others have mainly motility and chemotaxis
functionality (26,56,57). The systems demonstrated to have a role in global regulation
are Hpk2-Rrp2 and Hpk1-Rrp1. The Hpk2-Rrp2 TCS was the first system characterized
in Borrelia, consisting of the histidine protein kinase 2 (Hpk2) and response regulatory
protein 2 (Rrp2) (107). Rrp2 contains a DNA-binding helix-turn-helix domain which
regulates primarily plasmid-based genes including virulence factors such as OspC and
DbpA (14,36).
In contrast, the Hpk1-Rrp1 TCS is not well understood. This system contains the
histidine kinase-response regulator receiver protein 1(Hpk1; BB0420) and the response
regulator protein 1(Rrp1; BB0419) (70). Hpk1 is the proposed activator of the system,
but cooperation between these proteins has never been demonstrated. Unlike Rrp2,
Rrp1 lacks a DNA-binding output domain but contains a GGD/EEF enzymatic domain
which possesses diguanylate cyclase activity to convert two molecules of GTP to cyclic
8

diguanylate (c-di-GMP), an important bacterial secondary messenger (3,28,29,37). In
vitro diguanylate cyclase activity of Rrp1 has been demonstrated using recombinant
Rrp1 to produce c-di-GMP in a phosphorylation dependent manner (Figure 1-3) (27,77),
but in vivo activity has never been investigated.

Cyclic-di-GMP.
C-di-GMP is a ubiquitious signaling molecule utilized in a variety of bacterial
systems such as Vibrio, Escherchia, Pseudomonas, and Salmonella
(9,11,49,53,65,99,102). Modifications of intracellular c-di-GMP pools impact many
cellular processes including biofilm formation, virulence and persistence,
motility/chemotaxis, quorum sensing, et cetera (Figure 1-4) (34). High intracellular c-diGMP has generally been associated with increased biofilm production, sessility, and
persistence as a result of increased expression of exopolysaccharide in Vibrio and
adhesive fimbrae in Pseudomonas and Salmonella (38,42,101). In contrast, low
intracellular c-di-GMP promotes motility and virulence (86,100).
The dinucleotide is highly regulated by two opposing activities: biosynthesis and
hydrolysis. Synthesis is catalyzed by the diguanylate cyclase (DGC), while
phosphodiesterases (PDE) harboring EAL and/or HD-GYP domains hydrolyze c-diGMP via linear pGpG to two molecules of GMP (17,19,73,77,82,99). These proteins
are typically functionally redundant in many pathogens and greatly complicate research
schemes for understanding the full biological impact of c-di-GMP signaling (37).
However, Borrelia possess only one genomic copy of each of the c-di-GMP network
proteins including the diguanylate cyclase (Rrp1), EAL and HD-GYP
9

Figure 1-3. C-di-GMP synthesis by r-Rrp1. Recombinant Rrp1 was incubated with or
without acetyl phosphate prior to the addition of GTP. Resulting nucleotides were analyzed
by HPLC to assess Rrp1 activation and production of c-di-GMP.
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Figure 1-4. C-di-GMP regulation of bacterial cellular processes. Fluctuation of
intracellular c-di-GMP levels has been demonstrated to inversely regulate cellular states by
promoting sessility and biofilm formation in high c-di-GMP conditions and enhancing
motility and virulence during low c-di-GMP levels.
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phosphodiesterases (PdeA and PdeB, respectively), as well as one identified c-di-GMPbinding protein (PlzA) (27,41,63,70,96,97). The genes that encode each of these
proteins are also universally distributed throughout Lyme spirochetes species (Figure 15). Consequently, these organisms provide a simplified and ideal model to study
bacterial c-di-GMP signaling without redundancy complications. A representative
schematic of the hypothesized Borrelial c-di-GMP network is presented in Figure 1-6.
Recent studies suggest that c-di-GMP is a key regulator of B. burgdorferi
adaptive responses and may play an important role in the enzootic cycle
(27,63,70,77,97). The global regulatory ability of Rrp1, and by extension c-di-GMP, was
revealed through microarray analysis of an rrp1 deletion mutant (70). The Rrp1
regulon, which consists of ~10% of the genome, includes genes that encode proteins
spanning a wide range of functional categories with a concentration on motility,
chemotaxis, and metabolism (Figure 1-7). Several of the Rrp1 regulated genes encode
proteins that are likely to be in involved in the enzootic cycle. In addition, qRT-PCR
analysis of infected flat and fed ticks revealed that rrp1 expression is upregulated 6-fold
in fed ticks, indicating that Rrp1 may have an important role in cycle progression
particularly from Ixodes ticks to mammalian hosts (70).
As in other bacterial systems, c-di-GMP levels in B. burgdorferi are thought to be
controlled by the opposing activities of diguanylate cyclases and phosphodiesterases.
Borrelia strains encode an EAL domain phosphodiesterase (PdeA) and HD-GYP
domain phosphodiesterase (PdeB) (70,77,97). Both proteins are active PDEs within B.
burgdorferi and in vitro assays revealed the pathogen does not possess any other
proteins which hydrolyze c-di-GMP (96). In vivo, PdeA and PdeB are necessary for
12
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Figure 1-7. Rrp1 is a central regulator of the core Borrelia genome. Microarray
analysis of B31-5A13 wild type and rrp1 deletion strains revealed nearly 150 genes are
significantly regulated by Rrp1 (p<0.05) of which 84% are located on 3 genetic elements
that make up the core Borrelia genome (chromosome, lp54, cp26). The genes regulated
by Rrp1 have been organized by their genetic location (panel A) and by functional category
(panel B). Abbreviations: C, chromosome; ARS, amino acid biosynthesis; B, biosynthesis;
CE, cell envelope; CH, chemotaxis; F, flagellar biosynthesis; FM, fatty acid metabolism;
GM, general metabolism; HS, heat shock; IM, intracellular metabolism; NM, nucleotide
metabolism; PD, protein degradation; PE, protein export; PM, protein metabolism; R,
replication; RP, ribosomal proteins; TP, transport; TR, transcription. Number of genes
which are expressed at a higher or lower level in the Bb5A13-Ärrp1 strain relative to
Bb5A13-wt are indicated by the light or dark grey bars, respectively.
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enzootic cycle progression. Inactivation of PdeA abolishes murine infection by both
needle inoculation and natural tick feeding, but tick colonization capabilities are retained
(97). However, PdeB is only required for tick to mouse spirochete transfer (96). This
further supports c-di-GMP signaling as an important regulator of Lyme pathogenesis
and verifies the specific role of the network in spirochete host transitions. Successful
quantitation of spirochete intracellular c-di-GMP levels has yet to be completed to link
PDE virulence phenotypes directly to fluctuations in c-di-GMP cellular pools; however
this data identifies the need to investigate the direct or indirect mechanisms by which
these proteins are applying their effects.
Little is known regarding the effector mechanisms of c-di-GMP in the Lyme
disease spirochetes and arthropod-borne pathogens in general. In other bacterial
systems, c-di-GMP has been shown to exert its regulatory effects by interacting with
several different effector molecules including GEMM riboswitches (87,95), PilZ domaincontaining proteins (1,76), ribonucleoprotein complexes (103), and cyclic
monophosphate domains (35). Two PilZ domain-containing proteins (PlzA and PlzB)
have been identified in Borrelia strains, each possessing the RxxxR and DzSxxG motifs
associated with c-di-GMP binding (27). All strains produce the chromosomally encoded
PlzA protein, while a subset of strains carry the second gene encoding PlzB on a
variably sized linear plasmid. To date, only PlzA has been demonstrated to bind c-diGMP in a highly specific manner (Figure 1-8) (27) and shown to be essential for
mammalian disease and proper swarming (63). PlzB remains completely
uncharacterized and the effector functions of both PilZ domain-containing proteins have
not been defined.
16

Figure 1-8. C-di-GMP binds PlzA. Recombinant PlzA with a N-terminal maltose-binding
protein fusion was generated. In addition, point mutants possessing either a arginine to
aspartic acid or lysine change of both arginine residues within the RxxxR c-di-GMP binding
motif were created to evaluate PlzA binding to [á-32P] c-di-GMP. Proteins were spotted on
nitrocellulose and incubated with the competing nucleotide and respective ratio listed on
the right (competing nucleotide to radiolabelled c-di-GMP). r-Rrp was included as a
negative control and a anti-MBP immunoblot was performed to assess loading. PlzA
bound c-di-GMP with high specificity and disruption of the RxxxR motif abrogated this
interaction.
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Spirochete motility.
Spirochete migration through tissues is caused by the corkscrew-like motion
driven by the flagellar motors (80). Each spirochete harbors two periplasmic flagellar
bundles (consisting of 7-11 individual flagella structures) which anchor in the
cytoplasmic membrane and wrap around the protoplasmic cylinder (Figure 1-9A) (72).
A motor is located at each pole to coordinate flagellar rotation in opposite directions to
produce translational motion (runs and reverses) or rotation in the same direction to
cause cellular flexing (Figure 1-9B) (50). However, this translational motion pattern is
quite different from other pathogens which can only run and tumble, such as E. coli and
Salmonella. Runs are generated in these bacterial systems by flagellar counterclockwise rotation, while tumbles are produced by a direction reversal to clockwise
flagellar rotation (50).
Regulation of the motor rotation is controlled through the C-ring (flagellar motor
switch) which is composed of FliG, FliM, and FliN (50). This complex interacts with the
stator to energize rotation of the flagellar rotor (31). Borrelia possess two FliG proteins
(FliG1 and FliG2) instead of a singular FliG (26). FliG2 is believed to be equivalent to
the FliG protein of other bacterial systems, while FliG1 only localizes to one pole and its
function remains unknown (47).
Motility is a cellular process often affected by c-di-GMP signalling and c-di-GMP
has been identified to modulate flagellar motor control in E. coli and Salmonella (62).
The PilZ domain-containing protein, YcgR, has been shown to bind c-di-GMP and to the
flagellar motor switch (31). Inactivation of the protein suppresses a motility defect
(constant flagellar counter-clockwise rotation) initiated by the deletion of the EAL
18
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Figure 1-9. Borrelia burgdorferi flagellar structure. Lyme spirochetes possess two
flagellar bundles which wrap around the protoplasmic cylinder, anchoring at the poles
within the cytoplasmic membrane (Panel A). The motors are polarly located and consist of
the MS ring (FliF, base of the flagellar motor), C ring (FliG, FliM, and FliN; switch complex
regulation flagellar rotation), export apparatus, rod (connects MS ring and hook), L and P
rings (bushings at the membrane), and stator (motor force generator), as displayed in
Panel B.
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phosphodiesterase (YhjH) and elevated intracellular c-di-GMP levels (31). YcgR
controls this function by binding to the flagellar motor switch strongly in the presence of
c-di-GMP to reduce motor torque generation and cause a counter-clockwise motor bias.
This implicates the involvement of YcgR in a “backstop brake” mechanism (62).
This type of model has never been investigated in Borrelia, but Lyme spirochetes
possess the c-di-GMP network and the majority of flagellar and chemotaxis genes
present in other gram negative bacteria necessary for this type of flagellar motor control
(26). Deletion of the B. burgdorferi EAL phosphodiesterase or PilZ domain-containing
protein (PdeA and PlzA, respectively) decreases spirochete swarming and abrogates
murine infection supporting the hypothesis that c-di-GMP has a role in Borrelial motility
as well as virulence (27).

Together, this suggests c-di-GMP likely has a role in

spirochete motility but it could have an altered involvement in flagellar motor regulation
or be spatially localized due to the unique flagellar structure of spirochetes.

Study objectives
It is evident that c-di-GMP signaling is significant to bacterial pathogenesis in
many bacterial systems, yet there is a major lack of understanding of c-di-GMP
signaling on Borrelia cellular processes. The work presented here seeks to test the
hypothesis that the c-di-GMP network, and by extension c-di-GMP, regulates critical
steps in the enzootic cycle of the Lyme disease spirochetes. Our investigation is further
divided into three research goals; to first focus on the diguanylate cyclase, then
evaluate the PdeB phosphodiesterase, and lastly the PilZ domain-containing putative cdi-GMP effector proteins PlzA and PlzB. These analyses will aim to assess the impact
20

of each protein on intracellular c-di-GMP concentrations, infection, and enzootic cycle
progression by generating strains with targeted gene deletions utilizing allelic exchange
mutagenesis, followed by HPLC analysis, and infectivity testing using an Ixodes tickC3H-HeJ mouse model. Genetic alteration could drastically alter c-di-GMP pools and
respectively modify spirochete flagellar movement and chemotaxis. Therefore, we
additionally aim to identify if each protein is a critical regulator of spirochete motility and
chemotaxis by examining the ability of each deletion mutant to generate translation
motion, swarm, and respond to N-acetyl-D-glucosamine chemotaxis signals. These
analyses will provide unique insight into a relatively unexplored area of the role of c-diGMP signaling in the genetic regulation in B. burgdorferi and arthropod borne
pathogens.
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, and 25 µFD (22). After allowing the cells to recover for 24 hr in media
without selection, the strains were grown in BSK-H media containing 75 μg ml-1

CHAPTER 2: MATERIALS & METHODS

Bacterial isolates and cultivation.
All Borrelia burgdorferi strains generated in this study were constructed using the
low passage, B31-5A4 isolate (67) and maintained in BSK-H complete media with 5%
CO2 at 25, 33, or 37ºC. BSK-H media was prepared using bovine serum albumin from
Gemini Bio-Products, Inc (lot #C54) as previously described (79) and supplemented
with rabbit serum to 6% (Gemini). Spirochetes were harvested by centrifugation (4⁰C,
5,000 X g, 20 min) and washed with phosphate buffered saline (PBS).

Production of rrp1 allelic exchange constructs.
Allelic exchange replacement of rrp1 with an antibiotic resistance cassette was
performed as previously described using plasmid pΔBB0419 (Figure 2-1A) (70) to
generate the B. burgdorferi strain B31-Δrrp1. Prior to introduction of DNA into B.
burgdorferi by electroporation, 20 µg of the suicide plasmid was linearized with NcoI and
ScaI (NEB) according to the manufacturer’s protocol. This was done to increase
transformation efficiency and to inactivate the kanamycin and ampicillin resistance
cassettes. Electroporation was performed using the previously described conditions of
2.5 V, 200
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Figure 2-1. Schematics of plasmids for rrp1 allelic exchange and plasmid-based
constitutive expression. Plasmids in Panel A and B were generated using a pCR2.1
backbone that possessed the upstream flanking 1000 bp of the rrp1 with or without the
ORF. Additional features were added via restriction with the enzymes shown above. The
allelic exchange constructs in Panel A and B were used to create the B31-Ärrp1 and B31rrp1 KI strains, respectively. The pBSV2-based vector was produced by directionally
cloning the constitutive flaB promoter and rrp1 ORF into the plasmid multiple cloning site,
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B31-rrp1 OV mutant.
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streptomycin and clonal populations obtained by sub-surface plating (as described
below).
To complement the rrp1 deletion, rrp1 was reintroduced back into the
chromosome of B31-Δrrp1 using allelic exchange. To generate the construct for
complementation, a polymerase chain reaction (PCR) product extending from 1 kb
upstream of rrp1 to the 3' end of rrp1 (with 3' flanking AatII and AscI sites) was cloned
into pCR2.1 using TOPO-TA approaches (Invitrogen) to generate pBB0419-UP. A
kanamycin resistance cassette, derived from pBSV2 (93), with a 5' AatII site, was fused
by overlap extension to the downstream 1kb sequence flanking rrp1 (3' AscI site). The
kanamycin-downstream fusion was cloned into pCR2.1, digested with AatII and AscI
restriction enzymes (NEB), and then inserted into the pBB0419-UP to create pBB0419kan (Figure 2-1B). The resulting plasmid was purified, linearized with ScaI and NcoI
(NEB), and electroporated into B31-Δrrp1 to produce the complemented strain, B31rrp1 KI. Selection was achieved with 75 μg ml-1 kanamycin and clonal populations were
obtained by sub-surface plating.

Modification of the pBSV2 plasmid to constitutively produce rrp1.
Overexpression of rrp1 was accomplished by using a pBSV2 based plasmid (93)
with rrp1 expression under the control of the flaB promoter. The flaB promoter and
complete rrp1 gene were PCR amplified from B31-5A4 genomic DNA in separate PCR
reactions and cloned into pCR2.1-TOPO to yield pCR2.1-PflaB and pCR2.1-rrp1. The
plasmids were digested with ClaI and SalI (NEB). The rrp1 containing fragment was
excised from a gel and ligated into the pCR2.1-PflaB to yield pCR2.1-PflaB-rrp1. pBSV2
24

and pCR2.1-PflaB-rrp1 were linearized with BamHI and SalI (NEB). The PflaB-rrp1
fragment was ligated into the pBSV2 vector to generate pBSV2-PflaB-rrp1 (Figure 2-1C).
The final plasmid was propagated and electroporated into B31-5A4 cells. Selection of
the overexpression strain (B31-OV) was achieved using kanamycin (200 μg ml-1).
Clones were selected by sub-surface plating and plasmid content determined by PCR.

Generation of the plzA and pdeB deletion mutants and complementing strains.
Gene inactivation of plzA and pdeB was performed as described by (79). The 1
kb upstream and downstream of each open reading frame (ORF) was PCR amplified in
two separate reactions and cloned into the pCR2.1-TOPO vector to produce the
pBB0733-UP or pBB0374-UP and pBB0733-DN or pBB0374, respectively. The
upstream PCR fragment contained 3' flanking AatII and AgeI restriction sites, while the
downstream fragment possessed a 5' AatII and 3' AgeI site. The downstream 1 kb
amplicon was excised from the DN vectors with AatII and and AgeI restriction enzymes
(NEB), then ligated into the pBB0733-UP or pBB0374-UP vector to generate pBB0733UPDN and pBB0374-UPDN. A spectinomycin/streptomycin resistance cassette,
derived from pKFSS1-AatII (25), was inserted with flanking AatII sites between the 1 kb
up and downstream PCR fragments to produce pΔBB0733 and pΔBB0374 (Figure 2-2A
& Figure 2-3A, respectively). The plasmids were linearized with NcoI and ScaI, then
electroporated into infectious Borrelia burgdorferi 5A4 to generate the B31-ΔplzA and
B31-ΔpdeB, respectively. Selection for the deletion strains was achieved by
supplementing BSK-H media with 75 μg ml-1 streptomycin. Sub-surface plating was
utilized to isolate clonal populations.
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Complementation was obtained by allelic exchange mutagenesis of B31-ΔplzA
and B31-ΔpdeB to replace the spectinomycin/streptomycin cassette with the original
open reading frame harboring a 3' flanking kanamycin resistance cassette. A PCR
product containing 1 kb upstream of the select gene, the ORF, and 3' flanking AatII and
AscI sites, was TOPO cloned into pCR2.1 to generate pBB0733-UP+BB0733 and
pBB0374-UP+BB0374. A kanamycin resistance cassette was PCR amplified from
pBSV2 (93) with a 5' AatII site. Overlap extension PCR fused the kanamycin PCR
product to the 1000bp located immediately downstream of the targeted gene, and
added a 3' AscI site. The kanamycin-downstream fusions were TOPO cloned into
pCR2.1, then digested and ligated into the pBB0733-UP+BB0733 and pBB0374UP+BB0374 plasmids to create pBB0733-kan and pBB0374-kan (Figure 2-2B & Figure
2-3B). The plasmids were linearized with ScaI and NcoI then subsequently
electroporated into B31-ΔplzA or B31-ΔpdeB to produce the complemented strains,
B31-plzA KI and B31-pdeB KI. Selection was achieved with 75 μg ml-1 kanamycin and
clonal populations were isolated.

plzB allelic replacement of plzA.
Replacement of plzA with plzB was achieved by allelic exchange mutagenesis.
The upstream 1 kb region of plzA was PCR amplified to include the plzA ribosome
binding site (RBS) and cloned into pCR2.1-TOPO to generate plasmid pBB0733-UP-2.
The downstream 1 kb was excised from pBB0733-DN with AatII and AgeI and ligated
into pBB0733-UP-2 to create pBB0733-UPDN-2. Next, plzB (BBUZS7F20) was PCR
amplified from B. burgdorferi strain CA12 to include a 5’ AatII site and a 3’ overlap with
28

the PflgBkanR cassette. The PflgBkanR cassette was amplified from pBSV2 (93) to
possess a 5’ overlap with the 3’ plzB ORF and a 3’ AgeI restriction site. A plzBPflgBkanR fusion was created by overlap extension PCR, then digested with AatII and
AgeI, and ligated into pBB0733-UPDN-2 to produce pPlzB-kan (Figure 2-2C). pPlzBkan was linearized with ScaI and NcoI, electroporated into B. burgdorferi clone B31ΔplzA, and B31-ΔplzA::plzB transformants selected by cultivation in media containing
75 μg ml-1 kanamycin.

Isolation of clonal spirochete populations by subsurface plating.
One week post-electroporation, clonal isolates were obtained from transformed
cultures by subsurface plating. Plating was performed using 2% GTG agarose
(Seakem) and BSK-H complete media. The agarose was first autoclaved then
incubated in a 55⁰ water bath to cool. The media was simultaneously heated in a 45⁰
water bath. Each plate possessed a bottom 25 ml layer containing a 2:1 BSK to
agarose ratio. This layer was allowed to solidify before the pouring of the final top layer
which contained 1ml of a diluted transformed culture, 4 ml BSK-H, and 6.5 ml agarose.
The completed plates were allowed to cool and solidify at room temperature, and then
incubated at 33⁰ for ~2 weeks till colonies became visible. Clones were punched with a
sterile 1 ml pipet tip and ejected into a 2 ml microcentrifuge tube containing BSK-H and
appropriate antibiotic selection. Clonal cultures were incubated at 33⁰ and cultivated for
further verification and experimentation.
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Polymerase chain reaction verification of plasmid content and proper construct
integration.
To verify integration of the allelic exchange mutant constructs into their
respective chromosomal locations, PCR was performed with primers designed to
amplify inwards from locations outside the 1 kb upstream and downstream of the genes
replaced and outwards from the 5’ or 3’ locations of the gene and/or resistance
cassette. Primers used for each strain are listed in Appendix A. Upon PCR
confirmation of successful allelic exchange, plasmid content was assessed by PCR
utilizing primers specific for all 21 linear and circular plasmids as described by Rogers et
al (69). Evaluation of plasmid content was necessary to ensure a consistent genetic
background between strains and to maintain spirochete infection capabilities. Only
strains possessing all plasmids were used for further experimentation.

Growth curve analysis.
To determine growth rates for the mutant strains generated, an equal number of
actively growing spirochetes (33ºC) were transferred into fresh BSK-H complete media
without antibiotics and incubated at 25⁰, 33⁰, and 37⁰. Cells were counted every 24 hr
for 20 days using dark field microscopy. The average number of spirochetes per field
was determined by averaging the counts from 10 fields for each time point.

SDS-PAGE and immunoblotting.
Lysates were fractionated using 12.5% Criterion Precast Gels (BioRad) by
sodium dodecyl sulfate- polyacrylamide gel electrophoresis (SDS-PAGE) at 200 V for 1
30

hr and transferred to polyvinylidene difluoride membrane (Millipore) as previously
described (Rogers et al., 2009a). The membranes were blocked (1 x PBS, 0.2% tween,
5% non-fat dry milk) and screened with a variety of antisera including mouse anti-Rrp1
(1:1000), rat anti-FliG2 (1:500, gifted by Dr. Chunhao Li), rat anti-CheY3 (1:500, gifted
by Dr. Nyles Charon), mouse anti-Borrelia infection sera (1:1,000), and mouse anti-FlaB
(1:400,000). Antibody binding was detected using horseradish peroxidase-conjugated
goat anti-mouse IgG secondary antibody (Pierce -1:40,000) and SuperSignal West Pico
chemiluminescence substrate (Pierce).

RNA isolation and real time reverse transcriptase polymerase chain reaction
(qRT-PCR).
RNA was isolated from Borrelia cultures using the RNeasy Midi kit as described
by the manufacturer (Qiagen) and treated with DNase I (Invitrogen). cDNA was
generated using the Superscript III First Strand cDNA Synthesis kit (Invitrogen), 50 ng
random hexamer primers, and 1 μg total RNA. qRT-PCR was performed with SYBR
green PCR Master Mix (Applied Biosystems) and the CFX96 Real Time System
(BioRad) with primers listed in Appendix A. The following cycle parameters were used:
1 cycle of 10 min at 95º followed by 40 cycles of 10 sec at 94º, 30 sec at 50º, and 30
sec at 72º. Melting curves were generated over the temperature range 45-95º to
assess amplification specificity. All reactions were run in triplicate with three biological
replicates and the data were normalized against enolase (eno; BB0377). Statistical
analyses were performed using a paired, two-tailed t-test. Alterations of gene
expression were considered significant if p<0.05.
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Infectivity in mice: seroconversion and cultivation analyses.
The potential ability of each strain to infect C3H-HeJ mice (Jackson) was
assessed by subcutaneous needle inoculation of 104 spirochetes between the shoulder
blades (in 100 μl BSK-H complete media).

Four weeks post-inoculation, the mice were

sacrificed and blood, organs, and tissues were harvested. Seroconversion was
assessed by ELISA. The ELISA plates were first coated with 0.1 OD B31-5A4
spirochetes/ml in 100 μl of carbonate buffer (pH 9.6) overnight, then incubated for 2 hr
at RT with shaking, and blocked with 1% bovine serum albumin in PBS-T. Antiserum
from each mouse was applied in serial 3-fold dilutions (1:50-1:109,350) for 1 hr with
shaking at RT. The plates were then washed three times and bound IgG detected with
peroxidase conjugated goat-anti-mouse IgG antiserum (1:20,000) and ABTS
chromagen. Plate readings were taken at OD405 for each plate. Statistical analysis was
performed using a one-way ANOVA. In addition to the ELISA, seroconversion was
assessed through immunoblotting (1:1000 mouse anti-Borrelia sera) for confirmation.
Lastly, a third measure of infection was by cultivation. Tissues and organ biopsies were
immediately inserted into complete BSK-H media containing Borrelia antibiotic cocktail
(phosphomycin, rifampicin, and amphotericin B) and incubated at 33º for 2-3 weeks
followed by dark-field microscopy.

Tick studies.
Naïve larval stage Ixodes scapularis ticks (Oklahoma State University Tick
Rearing Facility) were brushed onto mice 4 weeks post-inoculation with each of the
strains described above. The ticks were fed to repletion, collected, and DNA isolated
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using the DNeasy Blood and Tissue kit (Qiagen). qPCR was performed using a B.
burgdorferi flaB primer set and the data were normalized against tick rDNA using the
RIB-3 and RIB-4 primers (109). Ticks were also infected using immersion methods
(64). Larval ticks were submerged in B. burgdorferi cultures (108 cells/ml; 33°C; 2 hr,
with shaking), washed, dried, and then fed on naive mice. One week after drop off,
DNA was isolated and analyzed by qPCR. Four weeks post-tick bite, the mice were
sacrificed and evaluated for infection by ELISA, immunoblot, and cultivation as
described above.

Motility analyses.
Motility in BSK-H complete media with and without 1% methylcellulose (Sigma)
was assessed using dark-field and differential interference contrast (DIC) microscopy.
Time lapse movies were recorded and analyzed using Slidebook 5 (Intelligent Imaging
Inovations) motion-tracking software. Each motion track was created by manually
marking individual spirochetes in consecutive frames. Velocity measurements were
calculated from twenty tracks per strain. Spirochete flexing was determined by manual
flex counts of twenty individual cells over the course of a track divided by total motion
track time. Statistics were performed using one-way ANOVA analysis. Microscopy was
performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility.

Swarm plate and capillary tube chemotaxis assays.
Swarm assays were adapted from Li et al (46) and Motaleb et al (55). Plates
containing 0.35% (wt/vol) Seakem GTG agarose in BSK-H were punched 3 times with a
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1 ml pipette tip. 5x105 spirochetes were resuspended in 5 μl of a 1:10 BSK-H dilution in
dPBS, and then placed in the punched holes. Plates were incubated at 33ºC and
colony diameters assessed at 2, 4, and 6 days using a caliper. Statistics were
generated using a one-way ANOVA on the means from 3 independent experiments.
The capillary assay was performed using a 96 well format as previously
described (56) with some modifications. All experiments were conducted in triplicate.
In brief, cells were harvested from liquid cultures by centrifugation and suspended at
107 cells ml-1 in motility buffer containing 1% (wt/vol) BSA and 1% (wt/vol)
methylcellulose (84). The cells were placed in the wells of a 96 well plate in triplicate for
each condition with 150 µl cell suspension per well. Capillary tubes, filled with motility
buffer plus or minus chemoattractant were inserted into the wells and the open end was
sealed with Critoseal (Leica). The plates were incubated at 33º for 2 hr and then the
contents of the capillary tubes were expelled into microcentrifuge tubes. The average
number of spirochetes per field using dark-field microscopy was determined by
averaging 10 fields of view. One-way ANOVA statistical analysis was performed on the
means from 3 separate experiments. Chemoattractants utilized include 0.1 M N-acetylD-glucosamine (Sigma), macerated whole-tick debris, 10 mM chitin (MP Biomedicals,
LLC), and 10 mM chitobiose (Sigma). For the assays utilizing chitin and tick debris, the
entire assembly was tilted on its side for the incubation period to prevent the insoluble
chemoattractant particles from settling out of the capillary tubes and into the wells.
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Intracellular c-di-GMP quantitation.
C-di-GMP determination in B. burgdorferi acid soluble extracts was performed as
previously described (2) with minor modifications. Borrelia cultures (50 ml) were grown
to and OD600 >2.0. Bacterial cells were collected by centrifugation (5,000 x g; 20 min;
4⁰C), washed with PBS, then centrifuged again to recollect cells. The pellet was
resuspended in 350 µl 0.4 M ice-cold HClO4 and lysed by sonication. After
centrifugation (16,000 x g; 3 min; 4⁰C) to remove cell debris, supernatants were
neutralized with 62 µl 0.8 M K2CO3, kept on ice for 10 min, and centrifuged (16,000 × g;
3 min; 4⁰C). Neutralized samples were injected into an HPLC system equipped with a
diode-array detector. Nucleotides separation was performed on a Sinergi 4.0 μ FusionRP 250 x 4.6 mm column (18⁰C; Phenomenex, Inc). Elution conditions were 12 min at
100% buffer A (100 mM potassium phosphate, pH 6.0), 8 min up to 12% buffer B (buffer
A containing 20% methanol), 3 min up to 45% buffer B, and 4 min up to 100% buffer B,
holding at 100% buffer B for 7 min, and returning to 100% buffer A in 6 min. Flow rate
was maintained at 1 ml min-1.

Generation and expression of recombinant proteins, PlzA and PlzB.
Primers were designed to amplify plzA, plzB, and rrp1 with 5’ BamHI and 3’ SalI
restriction sites. Products were digested and cloned into pCR2.1-TOPO, transformed
into TOP10 E. coli (Invitrogen), and positive colonies were selected by PCR. The
resulting plasmids were propagated and subcloned into pMAL-c4x (New England
Biolabs) via the BamHI and SalI restriction sites to produce the vectors pMAL-c4x PlzA,
pMAL-c4x PlzB, and pMAL-c4x Rrp1 (Figure 2-4). The resulting plasmids were
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Figure 2-4. Recombinant protein expression plasmids. The open reading frames of
plzA, plzB, rrp1, and wspR were PCR amplifed to contain flanking restriction sites (shown
above) for insertion into pMAL-c4x or pTYB12. Upon verification, r-proteins were induced,
purified, and utilized to synthesize c-di-GMP or assess r-protein c-di-GMP binding
capabilities.
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transformed into BL21 (DE3) E. coli cells for protein expression. Cells were grown at
37⁰ to an OD600 of 0.6, shifted to 23⁰, and induced with isopropyl-beta-D-1thiogalactopyranoside (IPTG; 1 mM; 3 h). After induction, cells were lysed via
sonication, and soluble protein was purified by amylose affinity chromatography as
instructed by New England Biolabs.

Synthesis of radiolabelled c-di-GMP.
Cyclic di-GMP binding assays were carried out as previously described (27). Cdi-GMP was enzymatically synthesized using recombinant WspR, cloned from
Pseudomonas aeruginosa FRG-1 into pTYB12 (New England Biolabs) using 5’ BsmI
and 3’ EcoRI sites to generate the pTYB12 WspR plasmid (Figure 2-4). To activate the
r-WspR, 5 µM of the protein was incubated with 25 µM acetyl phosphate for 30 min at
37⁰. Then, the acetyl phosphate treated r-WspR (5 μM) was incubated with
radiolabeled GTP [α-32P] (0.33 μM, Perkin Elmer) or non-radiolabeled GTP (200 μM,
Sigma-Aldrich) to generate both radiolabeled and cold c-di-GMP. Reactions were
incubated for 1 hr at 37⁰C. C-di-GMP concentrations and purity were assessed using
HPLC as described by Ryjenkov et al (77). GTP and unlabeled c-di-GMP served as
standards. Briefly, the samples were boiled, filtered (Ultrafree centrifugal filters;
Millipore), applied to a 15 x 4.6 cm Supelcosil LC-18-T column (Supelco), and
separated on an AKTApurifier (GE Health Sciences) by reverse phase HPLC. The
gradient system utilized buffers A (100 mM KH2PO4, 4 mM tetrabutyl ammonium
hydrogen sulfate, pH 5.9) and B (75% buffer A, 25% methanol). Nucleotides were
detected at a wavelength of 254 nm.
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PlzA & B c-di-GMP binding assays.
Cyclic di-GMP binding assays were carried out as previously described (27,65).
The recombinant proteins (0.25 μg r-PlzA, PlzB, and Rrp1 (negative control)) were
spotted onto nitrocellulose and allowed to air dry. The membranes were incubated with
[α-32P] c-di-GMP (2 nM) alone, or in combination with 750 nM of GTP, GMP, ATP,
cGMP, or cAMP (PBS with 1% milk; 2 h; RT). Membranes were washed twice with PBS
for 10 min and exposed to film overnight.
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CHAPTER 3: RESULTS

ANALYSIS OF THE DIGUANYLATE CYCLASE, RRP1.

Generation and analysis of an rrp1 deletion mutant, rrp1 over-expressing strain,
and cis-complemented strain.
To determine if Rrp1 regulates cellular processes required for completion of the
enzootic cycle, rrp1 of B. burgdorferi strain B31 clone 5A4 (an infectious clone) was
replaced by a spectinomycin/streptomycin resistance cassette (strepR) to yield strain
B31-Δrrp1 (Figure 3-1A). A functional cis-complemented strain, B31-KI (“knock-in”),
was generated by replacing the strepR cassette of B31-Δrrp1 with wild-type rrp1 and a
downstream kanamycin resistance cassette (Figure 3-1B). To generate a strain that
constitutively produces elevated levels of Rrp1, B31-wt was transformed with pBSV2PflaBrrp1 (Figure 3-1C) to yield a strain carrying a plasmid and chromosomal copy of
rrp1. Clonal populations of each strain were assessed for insertion of the cassette or for
the presence of the pBSV2-PflaBrrp1 plasmid using PCR (Figure 3-1D). The Borrelia
genome is segmented and consists of a linear chromosome and twenty or more linear
and circular plasmids (7). Genetic manipulation can result in the loss of plasmids
required for survival in mammals (44,66). To assess plasmid content, PCR was
performed with specific primer sets for each of the twenty one circular and linear
plasmids (data not shown) (54). Only clones harboring the full set of plasmids were
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Figure 3-1. Generation and verification of rrp1 deletion, complementation, and
overexpression. Schematics in panel A and B represent the chromosome of the B31Ärrp1 and B31-rrp1 KI complement mutants after allelic replacement, respectively.
Schematic C depicts the pBSV2-PflaBrrp1 plasmid construct utilized in this study for the
B31-OV mutant. Successful allelic exchange mutagenesis deleting and reinserting rrp1
was confirmed by PCR (Panel D), western blot (Panel E), and qRT-PCR analysis (Panel F).
Verification of pBSV2-based overexpression of Rrp1 was likewise performed by PCR
(Panel D), western blot (Panel E), and qRT-PCR (Panel F). Primers used for validation of
proper integration are indicated by numbers above the schematic arrows and are listed to
the left of the respective PCR panels. All primers used are listed in Appendix A.
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selected for further analyses. To evaluate Rrp1 protein and transcript levels,
immunoblot, and qRT-PCR analyses were conducted (Figure 3-1E &F, respectively).
rrp1 transcript and protein was detected in the B31-wt, B31-rrp1 KI, and B31-rrp1 OV
strains, but not in B31-Δrrp1. In vitro, B31-rrp1 OV produced 2-fold more rrp1 mRNA
than B31-wt or B31-rrp1 KI (Figure 3-1F).
In nature, B. burgdorferi encounters radically different environmental conditions
as it cycles between ticks and mammals. One environmental variable the pathogen
must adapt to during this enzootic cycle is temperature. Cultivation in the laboratory at
25⁰ to 27⁰C is thought to mimic at least in part the tick environment. Hence, we
determined growth rates at 27⁰, 33⁰, and 37⁰C (Figure 3-2). B31-Δrrp1 displayed an
extended lag phase at 27⁰C (7 days) and did not enter stationary phase for 13 days. All
remaining strains entered log phase within 2 days and stationary phase by day 7. It can
be concluded that Rrp1 is not required for growth in vitro, but its absence influences
growth at lower temperatures. This suggests that Rrp1 may play an important role in
the tick environment. Consistent with a potential role for Rrp1 and c-di-GMP in the tick,
rrp1 transcription has been demonstrated to be dramatically upregulated in ticks after
ingestion of a bloodmeal (70).

Analysis of c-di-GMP levels.
C-di-GMP production by each strain was assessed through HPLC analysis of
nucleotides extracted from in vitro cultivated bacteria in collaboration with Lee
Szkotnicki, PhD (former Marconi laboratory postdoctoral fellow), as well as Paola Bocci
and Nadia Raffaelli (Università Politecnica della Marche). This approach has been
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Figure 3-2. Rrp1 mutant growth curves. Growth of each strain was assessed at 27°, 33°
and 37° over twenty days in BSK-H complete media. Cultures were seeded at one cell per
400X field of magnification and average number of spirochetes per ten 400X fields was
determined every twenty four hours.
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successfully applied to measure c-di-GMP in E. coli (2) and it has a sensitivity of 0.3
pmol nucleotide/mg cells (data not shown). Borrelia hermsii DAH (tick-borne relapsing
fever) and Treponema denticola (periodontal disease) were included as controls. B.
hermsii harbors orthologs of each of the proteins which have been demonstrated to
participate in the synthesis and breakdown of c-di-GMP in B. burgdorferi, hence we
reasoned that it would behave similarly to the Lyme pathogen. T. denticola was
included because it actively produces several diguanylate cyclases during in vitro
cultivation (R.T. Marconi, unpublished data), thereby making it a good positive control
for c-di-GMP detection. In addition, because B. hermsii and T. denticola have a similar
membrane composition to B. burgdorferi (no lipopolysaccharide with a lipoprotein rich
outer membrane), we reasoned that they could serve as controls for the nucleotide
extraction process. C-di-GMP was readily detected in T. denticola but not in B. hermsii
(data not shown), B. burgdorferi B31-wt, B31-Δrrp1, B31-rrp1 KI, or B31-rrp1 OV
(Figure 3-3) demonstrating that c-di-GMP concentrations are inherently low in cultivated
Borrelia. This is consistent with the low level expression of rrp1 during in vitro
cultivation (70).

Demonstration that Rrp1 directly or indirectly influences infectivity and
dissemination and or secondary colonization of B. burgdorferi in mice.
Mice were subcutaneously needle inoculated with each strain and infection
assessed by seroconversion (ELISA and immunoblotting) 4 weeks post-inoculation
(Figure 3-4A). All mice inoculated with B31-wt, B31-Δrrp1, and B31-rrp1 KI were
seropositive with equivalent IgG titers. The B31-rrp1 OV strain had a significantly lower
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Figure 3-3.
Analysis of Borrelia burgdorferi intracellular c-di-GMP levels.
Nucleotides were extracted from in vitro cultivated rrp1 strains and c-di-GMP
concentrations quantitated by HPLC. Chromatograms of nucleotide extracts from each
strain are presented. The elution time of purified c-di-GMP is shown for reference.
Treponema denticola nucleotide extracts were assessed as a positive control.
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Figure 3-4. Rrp1 is not essential to mammalian infection, but overproduction
inhibits disease establishment. C3H-HeJ mice were needle inoculated subcutaneously
with 104 spirochetes (five mice per strain). Four weeks post-infection, mice were bled and
sera collected. Seroconversion was evaluated using whole-cell ELISA (Panel A) and
immunoblot (Panel B). Deletion of rrp1 did not alter the murine anti-Borrelial
immunological response in comparison to the wild type strain, however B31-rrp1 OV
exhibited a significantly lower anti-Borrelial IgG titer.
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IgG titer that all other strains (p<0.01). The low level IgG titer elicited by the B31-rrp1
OV strain is similar to that observed for other non-infectious isolates and it presumably
results from an antibody response to the inoculum itself (22). To compare antibody
responses evoked by each strain, the overall pattern of immunoreactive proteins
detected was determined by immunoblotting (Figure 3-4B). Consistent with the ELISA
data, serum from mice inoculated with B31-rrp1 OV did not recognize any proteins in
the immunoblot analyses. No significant differences in immunoreactive profiles were
observed with the serum collected from mice infected with B31-wt, B31-Δrrp1, and B31rrp1 KI.
To further assess infectivity, dissemination, and or secondary colonization,
biopsies from each mouse were collected from organs and tissues distal to the
inoculation site and placed in BSK-H media for spirochete cultivation. Cultures were
obtained from all clinical specimens recovered from B31-wt and B31-rrp1 KI inoculated
mice (Table 3-1). None of the heart biopsies and only a subset of the bladder and skin
samples harvested from B31-Δrrp1 inoculated mice yielded positive cultures. Positive
cultures were not obtained from mice inoculated with B31-rrp1 OV. This observation is
consistent with the immunological data described above. It can be concluded that Rrp1
is not required for infectivity but is required for maximal dissemination and or secondary
colonization.

Rrp1 is essential for spirochete acquisition by Ixodes scapularis.
To assess the ability of each strain to transit from infected mammals to feeding
ticks, larval stage Ixodes scapularis ticks were fed to repletion on mice (four weeks
46

Table 3-1. Murine infection study of rrp1 strains.

heart

skin

# spirochete positive cultures from each tissue or
organ biopsy

bladder

Strain

B31-wt

5/5

5/5

5/5

5/5

B31-Ärrp1

3/5 (mice
1 and 3
were
negative)

0/5

3/5 (mice
2 and 5
were
negative)

5/5

B31-rrp1 KI

5/5

5/5

5/5

5/5

B31-rrp1 OV

0/5

0/5

0/5

0/5
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# of culture
positive / # tested

post-inoculation), collected, DNA extracted, and qPCR was performed (Figure 3-5A &
B). Ticks fed on B31-wt and B31-rrp1 KI infected mice had an average of ~2.0 and ~2.4
flaB copies per 1000 tick genome equivalents indicating establishment of a productive
population in ticks. Spirochetes were not detected in ticks fed on mice inoculated with
B31-rrp1 OV or B31-Δrrp1. The results with the B31-rrp1 OV strain are as expected
since this strain did not establish a detectable infection in mice. To determine if the
B31-rrp1 OV and B31-Δrrp1 strains can survive in ticks, a mouse-independent route of
infecting ticks was employed. Larval ticks were submerged in cultures of each strain
and then fed on mice to provide bloodmeal derived nutrients (Figure 3-5B). The
efficiency of infecting ticks by this approach was 20 to 40% with each strain except B31Δrrp1 (0%). These data suggest that Rrp1 directly or indirectly regulates processes
which are required for survival in ticks.

Aberrant motility and chemotaxis patterns of the B31-Δrrp1 and B31-OV strains.
Several approaches were employed to determine if rrp1 deletion or elevated
production of Rrp1 regulates B. burgdorferi motility and or chemotaxis. General motility
patterns were assessed for spirochetes in BSK-H media with and without 1%
methylcellulose using dark-field and differential interference contrast (DIC) microscopy
in collaboration with Dr. Lee Szkotnicki. These studies utilized methylcellulose to
increase media viscosity in a matrix-dependent manner (74). All strains displayed wave
propagation but their translational motion patterns (directional forward movement) and
flex frequency differed (Figure 3-6). Note that all figures of motility depict cells that are
representative of the population as a whole. Consistent with earlier analyses of B.
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Figure 3-5. The diguanylate cyclase, Rrp1, is necessary for Ixodes infection.
Evaluation of spirochete acquisition by Ixodes ticks was assessed by qPCR. DNA was
isolated from naive ticks fed on infected mice till repletion (Panel A & B). Larval ticks were
also immersed into spirochete culture, washed, fed, and assessed for spirochete uptake
(Panel B).
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Figure 3-6. Translational motion patterns require Rrp1. Movement patterns of the
B31-wt, B31-Ärrp1, B31-rrp1 KI, and B31-rrp1 OV strains were visualized using DIC
microscopy. Images captured at five sec intervals are shown. Motion tracks were
manually recorded and overlayed on the images using motion tracking software. The
tracks are colored according to motion achieved during each time lapse (blue - 0 sec, green
- 5 sec, yellow - 10 sec, pink - 15 sec).
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burgdorferi motility, B31-wt moves short distances, flexes, and reverses direction (Table
3-2) (46,97). Motion-tracking revealed that B31-Δrrp1 had a faster run speed and a
significantly decreased flex frequency (p<0.01). Hence, it was locked in a constant
straight run (Table 3-2). In contrast, elevated production of Rrp1 as in the B31-rrp1 OV
strain had no effect on motility patterns. As expected, the B31-rrp1 KI strain displayed
motility patterns consistent with B31-wt. Motility was also assessed in semi-solid media
using swarm assays. The B31-Δrrp1 swarm diameter was found to be reduced by 47%
relative to B31-wt (p<0.01). The swarm diameters of B31-rrp1 KI and B31-rrp1 OV were
similar to B31-wt (Figure 3-7A and B). The results demonstrate that Rrp1, presumably
through its production of c-di-GMP, plays an important role in regulating flagellar motor
function.
C-di-GMP has been indicated to play a role in regulating chemotaxis in several
gram negative enteric bacteria (62). To determine if the presence or absence of Rrp1
directly or indirectly influences chemotaxis, capillary assays were performed using NAG
(Figure 3-7C). NAG is a known chemoattractant of B. burgdorferi (4,84). The B31Δrrp1 strain was highly attenuated in its NAG driven chemotactic response (p<0.05)
while the response of B31-rrp1 OV was not statistically different from that of the B31-wt
strain. Complementation of rrp1 (B31-rrp1 KI) restored wild type chemotactic responses
to B31-Δrrp1. Collectively, the data indicate Rrp1 is required for regulation of flagella
motor activity and NAG driven chemotactic responses.
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Table 3-2. rrp1 strain swimming patterns and observations.
Strain

BSK-H

1% methylcellulose

B31-wt

Motile

Translational motion: runs, stops/flexes,
reverses
Avg run velocity: 4.1426 ± 0.9442 µm/sec
Flexes/sec: 0.1738 ± 0.0319

B31-Ärrp1

Motile

Translational motion: runs with very
infrequent stops/flexes
Avg run velocity: 5.5815 ± 1.3920 µm/sec
Flexes/sec: 0.0150 ± 0.0430

B31-rrp1 KI

Motile

Translational motion; runs, stops
stops/flexes, reverses
Avg run velocity: 3.9116 ± 0.7613 µm/sec
Flexes/sec: 0.1429 ± 0.0679

B31-rrp1 OV

Motile

Translational motion; runs, stops
stops/flexes, reverses
Avg run velocity: 4.0359 ± 0.7859 µm/sec
Flexes/sec: 0.1593 ± 0.0340
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Figure 3-7. Rrp1 positively regulates motility and chemotaxis. The B31-wt, B31Ärrp1, B31-rrp1 KI, and B31-rrp1 OV strain motility and chemotaxis abilities were assessed
by swarming assay and capillary chemotaxis assay. Borrelia were spotted into punched
wells and diameters were measured at day 2, 4 and 6 (Panel B) from the respective swarms
(Panel A). Mutant movement toward N-acetyl-D-glucosamine was analyzed by capillary
assay. Spirochetes in capillary tubes with and without chemoattractant were counted after
a 2 hr incubation at 33° (Panel C). Mutants were compared to B31-wt for statistical
analysis.
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Transcriptional analysis of genes involved in NAG metabolism.
NAG, which is abundant in ticks and in glycosaminoglycans of mammalian
tissue, is required for in vitro growth of Borrelia (6). To determine if Rrp1 regulates the
transcription of genes involved in NAG metabolism, qRT-PCR analyses were
performed. The expression levels of nagA (NAG-6-phosphate deaminase), nagB
(glucosamine-6-phosphate-isomerase), ptsG (PTS system, glucose-specific IIBC
component), and ORF BB0002 (β-N-acetylhexosaminidase; a putative chitobiase) were
examined (Table 3-3). Deletion of rrp1 resulted in a significant decrease in the amount
of nagA and nagB mRNA but had no effect on BB0002 and ptsG (BB0645)
transcription. B31-rrp1 OV also had decreased nagB expression but transcription of the
other three genes was not significantly affected. These results indicate that Rrp1
directly or indirectly regulates the transcription of important genes involved in the
utilization of NAG. The decreased transcription of these genes could influence the
ability of B. burgdorferi to survive in tissues rich in NAG and in the tick.

Flagellar and chemotaxis gene regulation by Rrp1
Borrelia burgdorferi have complicated and redundant chemotaxis signaling
cascades to regulate flagellar motor directional bias, which remain poorly understood. It
is generally believed that CheY3 is the main chemotaxis response regulator that is
modified in various ways, including phosphorylation and possibly acetylation, to cause
adherence to the flagellar motor and ultimately favor rotation in a given direction (58).
The Rrp1-mediated modulation of flagellar and chemotaxis gene expression has been
demonstrated by microarray studies utilizing a rrp1 deletion mutant in a non-virulent
54

Table 3-3. Glucosamine metabolism pathway qRT-PCR analysis of the rrp1 strains.
Description

Functional
a
Category

Ärrp1/WT

p-value

OV/WT

p-value

BB0002 glycosyl hydrolase family 3
N domain protein (â-–
acetylhexosaminidase)

EM

0.2941

0.0536

0.4964

0.0996

BB0151 N-acetylglucosamine-6phosphate deaminase
(nagA)

IM

0.4611

0.0029

0.8787

0.2872

BB0152 glucosamine-6-phosphate
isomerase (nagB)

IM

0.3320

0.0176

0.4331

0.0319

BB0645 PTS system, glucosespecific IIBC component
(ptsG)

TP

0.4444

0.0921

0.5196

0.1137

a- As published in TIGR B. burgdorferi B31MI genome database.
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Borrelia burgdorferi strain 5A13 background. qRT-PCR was performed to determine if
specific flagellar and chemotaxis genes have altered gene transcription patterns as a
response rrp1 to inactivation or constitutive expression in a pathogenic clone 5A4
background. Primers were designed to evaluate the 54 known flagellar and chemotaxis
open reading frames (Appendix A). To date, tests have been completed for 21 of these
genes (Table 3-4), but the study remains ongoing. The constitutive strain did not exhibit
any significant transcript upregulation or downregulation in the selected motility and
chemotaxis panel, however this is expected since B31-rrp1 OV was not defective in
swarming or NAG chemotaxis. Surprisingly, 3 of 21 genes displayed significant
variations in transcription including a 3-4 fold induction of the flagellar-specific ATP
synthase (fliI), flagellar motor switch protein (fliG2), and chemotaxis response regulator
(cheY3) in the rrp1 deletion mutant. The upregulation of CheY3 was further verified by
immunoblot (Figure 3-8). Thus, Rrp1 and by extension c-di-GMP may control
chemotaxis by modulating CheY3 directly or indirectly via c-di-GMP effectors.

THE ROLE OF PLZA AND PLZB IN LYME ENZOOTIC CYCLE PROGRESSION

PlzB binds to cyclic-di-GMP with high specificity.
PilZ domain-containing proteins are key c-di-GMP effectors in a variety of
bacterial systems. Since this is the only type of effector identified in Borrelia
burgdorferi, we hypothesized that both Borrelial PilZ domain-containing proteins (PlzA
and PlzB) could affect enzootic cycle progression, motility, and NAG metabolism in a
similar manner as Rrp1. PlzA has been demonstrated to bind specifically to c-di-GMP
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Table 3-4. Flagellar and chemotaxis gene qRT-PCR analysis.
Functional
a
Category

KO/WT

p-value

OV/WT

p-value

BB0147 flagellin (flaB)

F

1.9131

0.1377

1.1505

0.4166

BB0149 flagellar hook-associated protein 2 (fliD)

F

0.8358

0.3620

0.8990

0.4055

BB0180 flagellar protein, putative

F

1.9063

0.1359

1.2763

0.3141

BB0182 flagellar hook-associated protein 3 (flgL)

F

1.1670

0.3981

1.2469

0.3343

BB0221 flagellar motor switch protein (fliG1)

F

2.6940

0.0999

2.0852

0.1223

BB0279 flagellar basal body-associated protein (fliL)

F

2.6364

0.0672

1.1231

0.4129

BB0284 flagellar basal body rod modification protein (flgD)

F

1.8132

0.1470

1.7409

0.1918

BB0288 flagellum-specific ATP synthase ( fliI)

F

4.2110

0.0351

1.6447

0.1780

BB0290 flagellar motor switch protein (fliG2)

F

3.9017

0.0443

2.0922

0.1159

BB0291 flagellar MS-ring protein (fliF)

F

1.8215

0.1413

1.1362

0.3981

BB0292 flagellar hook-basal body protein (fliE)

F

1.9752

0.1256

1.0747

0.4885

BB0294 flagellar basal-body rod protein (flgB)

F

2.0803

0.1114

0.8695

0.3944

BB0565 purine-binding chemotaxis protein (cheW2)

CH

3.1515

0.0627

1.1502

0.3944

BB0567 chemotaxis histidine kinase (cheA1)

CH

2.4525

0.0782

0.6776

0.2380

BB0570 chemotaxis response regulator (cheY2)

CH

1.6968

0.1871

0.9292

0.4428

BB0596 methyl-accepting chemotaxis protein (mcp2)

CH

0.8193

0.3515

0.8645

0.3871

BB0597 methyl-accepting chemotaxis protein (mcp3)

CH

2.2321

0.1175

0.7847

0.3208

BB0671 chemotaxis operon protein (cheX)

CH

1.6406

0.1871

0.8420

0.3656

Description

BB0672 chemotaxis response regulator (cheY3)

CH

3.3504

0.0482

1.1859

0.3691

BB0680 methyl-accepting chemotaxis protein (mcp4)

CH

2.1710

0.0973

0.4550

0.1838

BB0681 methyl-accepting chemotaxis protein (mcp5)

CH

1.0431

0.4732

0.4814

0.1377
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Figure 3-8. Chemotaxis response regulator, CheY3, is upregulated upon rrp1
deletion. Whole-cell lysates were probed with antisera directed against CheY3 and FliG2
to verify motility and chemotaxis qRT-PCR results. FlaB was included for loading control
and normalization purposes. Panel A depicts a representative immunoblot for each
antisera tested. Immunoblots from three separate experiments were scanned and
evaluated by spot densitometry analysis to determine protein abundance relative to FlaB
(Panel B).
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through the RxxxR binding motif located within the protein interior (27). Since PlzB
possesses the same conserved binding motif, the ability of PlzB to bind c-di-GMP was
assessed using ligand binding assays (study performed by John Courtland Freedman,
Marconi laboratory graduate student). As previously demonstrated with PlzA, PlzB
binds to c-di-GMP with high specificity as compared to PlzB incubated with the cold
competitor nucleotides GTP, ATP, cAMP, or cGMP. Coincubation of PlzB with
radiolabeled c-di-GMP and its cold c-di-GMP competitor displayed decreased signal as
compared to PlzB incubated with the radiolabeled dinucleotide alone, demonstrating
that the binding abilities of PlzB are specific for c-di-GMP (Figure 3-9).

Generation and characterization of a plzA deletion mutant and a plzB ciscomplemented strain.
The gene encoding PlzA is chromosomally located in all B. burgdorferi strains,
while plzB is only found on a plasmid in a few isolates. Hence, PlzB may not be critical
to strain virulence but could functionally complement PlzA for specific cellular
processes. To understand the role of both PlzA and PlzB in the pathogenesis of
Borrelia burgdorferi, allelic exchange mutagenesis was employed. The constructs for
allelic exchange mutagenesis were generated by Elizabeth Abdunnur, PhD (a former
postdoctoral research of the Marconi laboratory) and John Courtland Freedman. plzA
was first deleted from B. burgdorferi strain B31-5A4 by replacement of the ORF with a
spectinomycin/streptomycin resistance cassette (strepR) to yield the strain B31-ΔplzA
(Figure 3-10A). A cis-complemented plzA strain was generated by replacing the strepR
cassette of B31-ΔplzA with the plzA ORF and a downstream kanamycin resistance
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Rrp1

PlzB

PlzA
[32P]c-di-GMP alone

cold c-di-GMP (375:1)

cold GTP (375:1)

cold GMP (375:1)

cold ATP (375:1)

cold cGMP (375:1)

cold cAMP (375:1)

[32P]GTP alone

Figure 3-9. Borrelia burgdorferi PlzB binds to c-di-GMP with high specificity.
r-PlzA, r-PlzB, and r-Rrp1 were expressed with N-terminally located maltose binding
protein (MBP) fusions and evaluated for their [32P]c-di-GMP binding capabilities.
Competitive inhibitors tested are listed to the left of each panel with the respective inhibitor
to [32P]c-di-GMP ratio. The panels located at the top and second from the bottom were only
screened with the indicated nucleotide.
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Figure 3-10. Generation and confirmation of plzA deletion and complementation.
The chromosome of the B31-ÄplzA, B31-plzA KI, and B31-ÄplzA::plzB mutants after allelic
replacement are depicted in Panel A, B, and C, respectively. Successful mutagenesis was
verified by RT-PCR (Panel D) and PCR analysis (Panel E). RT-PCR was performed with
and without reverse transcriptase. Primers used for validation of proper integration are
indicated by numbers above the schematic arrows and are listed to the left of the respective
PCR panels. All primers used are listed in Appendix A.
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cassette (kanR) (Figure 3-10B). This strain was designated B31-plzA KI (KI indicating
“knock-in”). Lastly, plzA was replaced by plzB and a downstream kanamycin resistance
cassette to produce the B31-ΔplzA::plzB strain (Figure 3-10C). The B31-ΔplzA::plzB
strain was produced by John Courtland Freedman. Clonal populations of each strain
were evaluated for proper insertion of the cassette using PCR and multiple primer sets
(Figure 3-10E). Multiple clones of each strain harboring the expected insertions were
identified. The plasmid content of each clone was determined using plasmid specific
primer sets in PCR analyses (data not shown). Only clones possessing the 21 circular
and linear plasmids carried by the parental strain (B31-wt) were selected for further
analyses. Using RT-PCR analyses we confirmed that plzA transcription was eliminated
in the B31-ΔplzA strain only and plzB was only transcribed in the B31-ΔplzA::plzB
mutant (Figure 3-10D).
Spirochete growth rate was evaluated to identify potential growth defects (in
collaboration in John Courtland Freedman). Each strain was cultivated in BSK-H media
at 27⁰, 33⁰, and 37⁰ (Figure 3-11). The average number of spirochetes per ten fields
(400X magnification) was recorded for 20 days at 24 h intervals. All strains tested had
similar growth patterns.

PlzA is essential for establishing murine infection.
To evaluate if PlzA or PlzB is important for mammalian infection, C3H-HeJ mice
were subcutaneously injected with each strain. Four weeks post-inoculation, spirochete
infectivity was assessed by multiple approaches. Whole-cell ELISA (Figure 3-12A) and
immunoblot (Figure 3-12B) were employed to analyze seroconversion of each mouse.
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Average # of spirochetes/field

10000

B31-wt - 27°
B31-wt - 33°
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B31-wt - 37°
B31-ÄplzA - 27°
B31-ÄplzA - 33°

100
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0.1

Days

Figure 3-11. Growth curve analysis of plzA and plzB strains. Spirochetes were grown
for twenty days at 27°, 33°, and 37°. Average number of cells per ten 400X fields of
magnification was calculated every 24 h for 20 days.
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Figure 3-12. PlzA is essential to mammalian infection.
C3H-HeJ mice were
inoculated by a subcutaneous needle injection with 104 spirochetes per strain. Four weeks
post-infection, mice were bled by tail-nick and sera was isolated. Seroconversion was
assessed using whole-cell ELISA (Panel A) and immunoblot (Panel B).
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Both the B31-wt and B31-plzA KI elicited an immunological response with equivalent
IgG titers, while the B31-ΔplzA and B31-ΔplzA::plzB strains were not positive for
seroconversion (p<0.01). Immunoblots with B31-wt whole cell lysates and pooled sera
samples were used to verify the ELISA results and visually compare the antibody
responses of each strain. The protein banding pattern of the B31-wt and B31-plzA KI
strain was similar, indicating antigenic profiles were unaltered by the genetic
manipulation. As previously indicated by ELISA, the deletion mutant nor plzB
complement did not produce immunological responses.
Upon sacrifice, biopsies and organs were collected and immediately placed in
BSK-H media for cultivation to analyze spirochete survival within the isolated tissues.
All cultures were positive, except the B31-ΔplzA and B31-ΔplzA::plzB strains did not
yield any outgrowth (Table 3-5) (B31-ΔplzA::plzB strain cultivation was performed by
John Courtland Freedman). This data is consistent with the immunological studies,
showing the deletion mutant was unable to establish a productive infection within mice
and the B31-ΔplzA::plzB strain was not able to replace the function of PlzA in a
mammalian disease model.

Infection and survival in Ixodes scapularis ticks does not require PlzA or PlzB.
To test the ability of the plz strains to persist within ticks, immersion feeding was
investigated. Laboratory reared, pathogen free, naive Ixodes scapularis larval ticks
were immersed in actively growing cultures of each strain and then fed on naive mice
until repletion. qPCR of DNA extracted from the ticks revealed that all strains tested
were able to establish productive populations (Table 3-6). Additionally, the naive mice
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Table 3-5. Plz mutant murine infection study.

heart

skin

# spirochete positive cultures from each tissue or
organ biopsy

bladder

Strain

B31-wt

5/5

5/5

5/5

5/5

B31-ÄplzA

0/5

0/5

0/5

0/5

B31-plzA KI

5/5

5/5

5/5

5/5

B31-ÄplzA::plzB

0/3

0/3

0/3

0/3
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# of culture positive / #
tested

Table 3-6. Plz strain tick to mouse spirochete transmission.
Strain

# of ticks positive / # tested

# of mice positive / # tested

B31-wt

10/10

3/3

B31-ÄplzA

8/10

0/3

B31-plzA KI

8/10

1/3

B31-ÄplzA::plzB

10/10

0/3
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used for the feeding were assayed for seroconversion by whole-cell ELISA and
immunoblot (Figure 3-13) to evaluate spirochete natural transmission. Confirming
infection results via subcutaneous inoculation, the B31-ΔplzA and B31-ΔplzA::plzB
strains were incapable of establishing an infection by tick transmission. Therefore, it
can be concluded that PlzA and PlzB are not required for B. burgdorferi to infect ticks.

Aberrant motility and chemotaxis patterns of the B31-ΔplzA and B31- ΔplzA::plzB
strains.
The potential effects of plzA deletion and replacement with plzB on spirochete
motility and chemotaxis were investigated. The motility of each strain was analyzed by
DIC microscopy (study conducted by Lee Szkotnicki, PhD). Still images from 0, 10, and
20 sec time points of a representative movie for each strain are presented in Figure 314. All strains were capable of translational motion. B31-wt exhibited normal motility
patterns with a short run, followed by turns, flexes, and direction reversal (Table 3-7).
B31-ΔplzA had significantly slower run speeds than wild-type and a reduced flexing
frequency, resulting in a slow constant run with infrequent stops (p<0.01). The B31plzA KI strain displayed motion patterns consistent with B31-wt, while the B31ΔplzA::plzB mutant exhibited a phenotype similar to the plzA deletion mutant with a
reduced average run velocity and flexing frequency (p<0.01). To further assess the
motion patterns defects associated with PlzA deletion, swarm assays were performed in
BSK-H semi-solid media (Figure 3-15). Both B31-ΔplzA and B31-ΔplzA::plzB had
significantly reduced swarms relative to B31-wt by approximately 43% (p<0.05). The
B31-plzA KI swarm diameter was comparable to B31-wt. N-acetyl-D-glucosamine
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Figure 3-13. Tick to mouse transmission requires PlzA. Ticks infected by immersion
methods were fed on C3H-HeJ mice. Four weeks post-infection, mice were bled by tailnick and sera was isolated. Seroconversion was assessed using whole-cell ELISA (Panel
A) and immunoblot (Panel B). The circles in Panel A represent individual mice.
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0 sec

10 sec

20 sec

B31-wt

B31-ÄplzA

B31-plzA KI

B31-ÄplzA::plzB

Figure 3-14. Deletion of plzA prevents translational motion. DIC microscopy was
utilized to track the movement patterns of the strains. Images were captured at five sec
intervals. Spirochete tracks were manually recorded and overlayed on the images using
motion tracking software. Motion acheived during each time lapse is color coded
according to the respective 10 sec period (blue - 0 sec, yellow - 10 sec, pink - 20 sec).
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Table 3-7. Motility analysis of plzA and plzB strains.
Strain
B31-wt

BSK-H
Motile

1% methylcellulose
Translational motion: runs, stops/flexes,
reverses
Avg run velocity: 4.1578 ± 0.7788 µm/sec
Flexes/sec: 0.0783 ± 0.0313

B31-ÄplzA

Motile

Translational motion: runs with very
infrequent stops/flexes and low speed
Avg run velocity: 1.6500 ± 0.7339 µm/sec
Flexes/sec: 0.0043 ± 0.0115

B31-plzA KI

Motile

Translational motion; runs, stops
stops/flexes, reverses
Avg run velocity: 4.1706 ± 0.8714 µm/sec
Flexes/sec: 0.1024 ± 0.0541

B31-ÄplzA::plzB

Motile

Translational motion; runs, stops
stops/flexes, reverses
Avg run velocity: 1.5793 ± 0.7369 µm/sec
Flexes/sec: 0.0078 ± 0.0109
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Figure 3-15. PlzA positively regulates motility. The B31-wt, B31-ÄplzA, B31-plzA KI,
B31-ÄplzA::plzB were evaluated for motility and chemotaxis abilities by swarming and
capillary chemotaxis assay. Spirochetes were spotted into punched wells of agarose
plates. Diameters were measured 2, 4, and 6 days post-plating (Panel B). Representative
swarms are shown in Panel A. Strain migration towards N-acetyl-D-glucosamine was
tested by capillary assay (Panel C). Spirochetes contained within capillary tubes were
enumerated after a 2 h incubation at 33° with or without chemoattractant.
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(NAG) capillary chemotaxis assays were utilized to determine if the deficiency is due to
reduced migration towards defined chemoattractants (Figure 3-15C). All strains
exhibited a NAG chemotactic response. Altogether, this data suggests that PlzA is
necessary for proper flagellar motor regulation but not NAG chemotaxis, second that its
role in Borrelial motility cannot be complemented by PlzB.

Transcriptional analysis of the genes involved in the NAG metabolic pathway.
Intracellular c-di-GMP levels are suggested to impact NAG chemotaxis and
genes involved in NAG metabolism (41). Since PlzA is a c-di-GMP effector and shown
by capillary assay to not regulate NAG chemotaxis, qRT-PCR analysis was conducted
to confirm PlzA does not elicit a change in NAG metabolism, as was seen by the
diguanylate cyclase. The expression levels of nagA (NAG-6-phosphate deaminase),
nagB (glucosamine-6-phosphate-isomerase), ptsG (PTS system, glucose-specific IIBC
component), and ORF BB0002 (β-N-acetylhexosaminidase; a putative chitobiase) were
analyzed (Table 3-8). Gene expression was not significantly affected by the deletion of
plzA, verifying the capillary chemotaxis assay results.

THE PHOSPHODIESTERASE, PDEB, REGULATES TRANSMISSION
FROM IXODES TICKS

Production of a pdeB deletion mutant and its cis-complemented strain.
C-di-GMP levels are balanced and controlled by the opposing activities of the
diguanylate cyclases and phosphodiesterases. B. burgdorferi possess both an EAL and
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Table 3-8. Glucosamine metabolism pathway qRT-PCR analysis of the
plzA strains.
Functional
a
Category

ÄplzA/WT

p-value

BB0002 glycosyl hydrolase family 3
N domain protein (âacetylhexosaminidase)

EM

0.9925

0.6647

BB0151 N-acetylglucosamine-6phosphate deaminase
(nagA)

IM

1.2394

0.9541

BB0152 glucosamine-6-phosphate
isomerase (nagB)

IM

0.6016

0.3299

BB0645 PTS system, glucosespecific IIBC component
( ptsG)

TP

0.3721

0.3721

Description
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HD-GYP phosphodiesterase (PdeA and PdeB, respectively) for c-di-GMP degradation.
Since disruption of pdeA prevented mammalian infection (97) similarly to the
constitutive diguanylate cyclase strains (B31-rrp1 OV), we hypothesized that
mutagenesis of pdeB would also impact pathogen virulence. The study detailed below
was performed in collaboration with Dr. Lee Szkotnicki.
To understand the role of PdeB in B. burgdorferi pathogenesis, allelic exchange
mutagenesis was utilized to delete and complement pdeB in the infectious B31-5A4
clone (performed by Lee Szkotnicki, PhD). Generation of the deletion mutant (B31ΔpdeB) involved the replacement of the gene ORF with a spectinomycin/streptomycin
resistance cassette (strepR) (Figure 3-16A). Complementation was achieved by
reinserting pdeB in its original chromosomal location with a 3’ flanking kanamycin
resistance cassette (kanR) (Figure 3-16B). This strain was designated B31-pdeB KI.
Successful transformants were screened for proper construct integration by PCR
(Figure 3-16D) using multiple primer sets shown in Appendix A. Clones of each strain
containing the desired insertions were subsequently screened for plasmid content (data
not shown). All selected clones possessed the complete set of 21 circular and linear
plasmids present within the parental B31-5A4 strain. The disruption of pdeB
transcription and reestablishment of expression by the selected B31-ΔpdeB and B31pdeB KI clones, respectively, was confirmed by qRT-PCR analyses (Figure 3-16C).
Growth rate of each strain was assessed to determine if growth defects arose
from genetic manipulation of pdeB. Spirochetes were cultivated in BSK-H media at 27⁰,
33⁰, and 37⁰ (Figure 3-17) (assay conducted by Lee Szkotnicki, PhD). The average
number of spirochetes per ten fields (400X magnification) was recorded for 13 days at
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Figure 3-16. Construction and verification of pdeB deletion and complementation
mutants. Panel A and B display schematics representing the chromosome of the B31ÄpdeB and B31-pdeB KI mutants after allelic exchange mutagenesis. Successful
recombination was verified by qRT-PCR (Panel C) and PCR analysis (Panel D). Primers
used for validation of proper integration are indicated by numbers above the schematic
arrows and are listed to the left of the respective PCR panels. All primers used are listed in
Appendix A.
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Figure 3-17. PdeB strains exhibit normal growth patterns. Strain growth curves were
assessed for thirteen days at 25°, 33°, and 37°. Spirochetes were enumerated every
twenty four hours and average number of cells per ten 400X magnification field was
calculated.
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24 h intervals. No significant growth differences were discovered between the mutants
and the wild type strain at the various temperatures.

Murine infection via needle inoculation does not require PdeB.
To identify if PdeB is essential for mammalian infection, C3H-HeJ mice were
subcutaneously inoculated with 104 spirochetes of each strain (study performed in
collaboration with Lee Szkotnicki and assistance from Katie Mallory). Four weeks postinoculation, the spirochete infection capabilities were evaluated using cultivation and
seroconversion methods. Bladder, heart, and skin tissue biopsies were harvested from
each mouse after sacrifice and inserted immediately into BSK-H growth media for
Borrelia cultivation (Table 3-9). The B31-wt, B31-ΔpdeB, and B31-pdeB KI strains all
yielded outgrowth from every tissue, demonstrating PdeB is not necessary for disease
establishment of B. burgdorferi. To confirm biopsy cultivation results, whole-cell ELISA
(Figure 3-18A) and immunoblot (Figure 3-18B) were employed to assess murine
immunological responses. As shown by the tissue outgrowth, all strains retained the
infection abilities of the B31-wt strain as indicated by the production of equivalent IgG
titers. Immunoblots, with B31-wt whole cell lysates and pooled sera, also displayed
identical banding patterns which verify antigenic similarity between the tested strains.

PdeB is critical for natural transmission via infected Ixodes ticks.
Despite lacking significance in murine infection by needle inoculation, the PdeB
still could serve as a key factor in tick colonization and Borrelial enzootic cycle
progression. To first identify if deletion of pdeB inhibits spirochete transfer to ticks,
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Table 3-9. Murine study of pdeB mutant infection capabilities.

joint

skin

# spirochete positive cultures from each tissue or
organ biopsy

bladder

Strain

B31-wt

3/3

3/3

3/3

3/3

B31-ÄpdeB

3/3

3/3

3/3

3/3

B31-pdeB KI

3/3

3/3

3/3

3/3
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# of culture positive / #
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A.
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Figure 3-18. PdeB is not essential for murine infection via subcutaneous needle
inoculation. Immersion-infected ticks were fed on C3H-HeJ mice. Four weeks postinfection, mice were bled by tail-nick and sera was isolated. Seroconversion was
assessed using whole-cell ELISA (Panel A) and immunoblot (Panel B). The circles in
Panel A represent individual mice.
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three mice per strain were needle inoculated subcutaneously. Four weeks postinoculation, infection was confirmed (as described above) and naive larval Ixodes ticks
were allowed to feed on the mice until repletion. qPCR was performed on DNA isolated
from the collected ticks one week post-feeding. All strains were capable of infection;
however the B31-ΔpdeB strain infected at a lower frequency (20%) than B31-wt (80%)
and B31-pdeB KI (100%) (Table 3-10). To assess whether this decreased tick
colonization efficiency affects natural transmission to uninfected mice, naïve larval ticks
were infected by each strain via immersion methods and then fed on naïve mice. Tick
colonization frequency was assessed by qPCR. All strains were efficient in tick infection
ability by both methods. B31-ΔpdeB was more readily acquired by ticks using
immersion techniques compared to natural tick infection.
Spirochete transmission to the naïve mice was evaluated by biopsy cultivation
(Table 3-10) and seroconversion analysis (Figure 3-19). Surprisingly, B31-ΔpdeB was
not able to persist in mice via tick bite as was done by B31-wt and B31-pdeB KI, despite
its ability to establish murine infection by needle inoculation. This suggests that pdeB
has a functional role in spirochete transmission and migration between hosts or that
pdeB could interfere with tick colonization processes, as implicated by decreased tick
colonization efficiency. In addition, the deletion mutant presents a unique infection
phenotype which is not presented by any of the c-di-GMP network Borrelia mutants
constructed and tested thus far, including the pdeA deletion strain of Sultan et al (97).
Thus, this indicates that pdeB may have an additional function in vivo which is not
shared by the EAL phosphodiesterase, PdeA.
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Table 3-10. Acquisition and transmission of the pdeB mutants.
Strain

Natural

Immersion

# of ticks positive /
# tested

# of ticks positive / #
tested

# of mice cultivation
positive / # tested

B31-wt

8/10

8/10

3/3

B31- ÄpdeB

2/10

5/10

0/3

B31-pdeB KI

10/10

6/6

2/3
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Figure 3-19. Natural spirochete transmission requires pdeB. C3H-HeJ mice were
inoculated with 104 spirochetes per strain by a subcutaneous injection. Four weeks postinfection, mice were bled by tail-nick and sera was isolated. Whole-cell ELISA (Panel A)
and immunoblot (Panel B) were used to evaluate seroconversion. The circles in Panel A
represent individual mice.
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Induction of abnormal spirochete morphology and motility upon pdeB deletion.
To investigate the impact of pdeB on spirochete motility, DIC microscopy was
coupled with motion tracking software to evaluate the motion patterns of each strain
(analysis performed by Lee Szkotnicki, PhD). Movies were recorded and overlaid with
tracks of cellular motion. Still images from 0-7 sec time points of a representative
movie for each strain are presented in Figure 3-20. Both the B31-wt and B31-pdeB KI
strains retained normal flat wave morphology, as well as translational motion patterns.
However, B31-ΔpdeB possessed an abnormal morphology and loss of cellular waves.
The strain also exhibited a constant flexing phenotype and was incapable of
translational motion when visualized in BSK-H containing 1% methylcellulose. This may
be due to disruption of normal flagellar structure and bundles, which could prevent
cellular translational movement. As well, regulation of the flagellar motor direction could
be altered to lock both flagellar bundles rotating in the same direction, causing a flex.
Further analyses were conducted to determine if this motility defect correlates
with swarming and chemotaxis capabilities utilizing swarming (Figure 3-21A &B) and
NAG capillary chemotaxis assays (Figure 3-21C) (study performed in collaboration with
Lee Szkotnicki, PhD). Interestingly, B31-ΔpdeB was able to swarm (with only a 30%
reduction) and chemotax despite the lack of translational motion in BSK-H containing
1% methylcellulose and the obvious defect in flat wavelength morphology. Thus, the
reduced swarming is not due to changes in NAG chemotaxis and may be a result of the
disruption of cellular flat wave morphology and state of flexing.
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Figure 3-20. pdeB deletion alters spirochete morphology and motility. To assess the
motility patterns, cells were assessed by DIC microscopy and time lapse imaging. Still
images captured at one sec intervals are presented above. Flexes are indicated in Panel A
& C, while B31-ÄpdeB (Panel B) remains in a state of constant flexing.
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Figure 3-21.
Deletion of pdeB results in decreased spirochete swarming.
Spirochetes were spotted into punched wells of agarose plates to measure strain
swarming. Diameters were measured 2, 4, and 6 days post-plating (Panel B).
Representative swarms are shown in Panel A. Spirochete chemotaxis towards N-acetylD-glucosamine was evaluated by enumerating cells expelled from capillary tubes after a 2
h incubation at 33° with or without chemoattractant (Panel C).
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CHAPTER 4: DISCUSSION

In the Lyme disease spirochete, B. burgdorferi, c-di-GMP has been postulated to
regulate cellular processes required for completion of the enzootic cycle (27,63,70,97).
Until the completion of this study and recent work by Motaleb and colleagues, the
Borrelial c-di-GMP signaling network remained uncharacterized and its role in Lyme
pathogenesis completely unknown. Since 2009, this area of study has rapidly
expanded and provided significant new insight into the genetic regulatory mechanisms
of the B. burgdorferi enzootic cycle and c-di-GMP signaling in arthropod-borne
pathogens.

Rrp1 regulation of virulence and chemotaxis.
The synthesis of c-di-GMP was the initial research target to understand how
production of Rrp1, the sole diguanylate cyclase, affected intracellular c-di-GMP
concentrations, as well as regulation of the Borrelial genome. Previous studies
demonstrated that the deletion of rrp1 results in pronounced changes within the B.
burgdorferi transcriptome and identified key groups of genes which are regulated by the
diguanylate cyclase including flagellar biosynthesis, chemotaxis, transport, and
nucleotide/amino acid metabolism (70). Since Rrp1 lacks a DNA binding domain or
other known functional domains, its regulatory capability is thought to be linked
specifically to its diguanylate cyclase activity. Until this study, the potential requirement
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for c-di-GMP over the course of the enzootic cycle of a tick-borne bacterial pathogen
has not been assessed. Recent analyses of B. burgdorferi pdeA (EAL domain
phosphodiesterase) and plzA (PilZ domain c-di-GMP binding protein) mutants, which
display attenuated virulence, have provided indirect evidence that c-di-GMP is an
important regulatory molecule in vivo (63,97). The Lyme disease spirochetes offer an
excellent model system for studying diguanylate cyclase mediated regulation over the
course of the enzootic cycle because B. burgdorferi can be genetically manipulated and
there is a well characterized and biologically relevant mouse-tick enzootic model.
In this study, we tested the hypothesis that high c-di-GMP levels interfere with
passage of spirochetes from ticks to mammals (transmission stage) while the absence
of c-di-GMP attenuates the ability of B. burgdorferi to transit from mammals to ticks
(acquisition phase). To assess these possibilities, strains that lack rrp1 (B31-Δrrp1) or
produce it at elevated levels (B31-OV) were generated. While B31-Δrrp1 retained its
ability to infect mice the B31-OV strain was not infectious. B31-Δrrp1 was also found be
less efficient at dissemination and/or secondary colonization as it was not cultivated
from heart biopsies and was inconsistently cultured from biopsies collected from sites
distal to the inoculation site. In addition, while B31-Δrrp1 readily infected mice, natural
tick feeding experiments revealed that this strain is not able to transit into ticks and
establish a productive population. Recently, this phenotype was shown to be exhibited
by a strain possessing an inactive form of the cognate histidine kinase of Rrp1, Hpk1,
providing further evidence that Rrp1 function and c-di-GMP synthesis is required for
spirochete survival within ticks (16). Because B31-OV cannot infect mice, we were not
able to assess its potential to transit from mammals to ticks via natural tick feeding. To
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allow us to assess the ability of this strain to survive in ticks an immersion feeding
approach was employed (64). B31-OV established a productive population in ticks
while B31-Δrrp1 did not. The data presented here and in earlier studies suggest that cdi-GMP levels regulate processes involved in transmission, acquisition, and survival of
B. burgdorferi in ticks (70,97).
The inability of the B31-Δrrp1 to transit from ticks to mammals and/or survive in
ticks could be due to impaired chemotactic responses or the inability to efficiently utilize
tick derived nutrients. Earlier transcriptional analyses demonstrated that genes which
encode proteins involved in chemotaxis (che and mcp) and NAG utilization (nagA and
nagB) are positively regulated by Rrp1 (70). Consistent with the transcriptional data, a
75% reduction in the chemotactic response of B31-Δrrp1 to NAG was observed.
Complementation restored wild type chemotactic responses to NAG. Wild type levels of
nagA and nagB transcription were also restored by complementation. NAG, which is a
major constituent of chitin and chitobiose, is highly abundant in the peritrophic
membrane of the tick midgut (75,110). The inability of B31-Δrrp1 to pass from infected
animals into ticks could be due to the reduced ability of this strain to sense tick derived
NAG and migrate to the tick bite site. It stands to reason that efficient acquisition would
be dependent on such responses and that the ability of B. burgdorferi to survive in ticks
would require efficient utilization of NAG.
Studies of other bacteria indicate an inverse correlation between c-di-GMP levels
and bacterial motility (40,53,62,86,104). The influence of Rrp1 on motility of B.
burgdorferi was first assessed by evaluating basic flagella motor function with wave
propagation as a read out. All strains displayed wild type wave propagation patterns.
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To assess translational motion (i.e., directional movement away from the point of origin)
methylcellulose was added to the media (74). In standard BSK-H media, which lacks
methylcellulose, spirochetes display limited translational motion due to low viscosity and
the absence of an inherent matrix. For spirochetes to undergo translational motion, the
flagella motors located at each end of the cell must rotate in opposite directions (i.e.,
clockwise and counterclockwise). When the flagella motors rotate in the same direction,
the cells flex, unlike when both flagella motors reverse direction, a change in direction
occurs (18). All strains had translation motion but B31-Δrrp1 was drastically reduced in
flex frequency and was locked in constant one-directional motion. Failure to reverse
and translation in one direction is associated with chemotaxis-deficient Borrelial cells
(46), suggesting a link between the motility defect and lack of NAG chemotaxis
associated with rrp1 deletion.
Specifically, B31-Δrrp1 mimics the phenotype of a B. burgdorferi cheY3 deletion
mutant (58). CheY3 is an important chemotaxis response regulator which can alter
flagellar rotation in a phosphorylation dependent manner. To balance and control the
actions of CheY3, Borrelia possess the phosphatase, CheX (56). Upon inactivation of
CheX, spirochetes elicit a constant flex phenotype which is indicative of high levels of
the CheY3 in its phosphorylated state, CheY3-P. This may suggest that disruption of
Rrp1 prevents accumulation of CheY3-P. To understand the impact of Rrp1 on cheY3
and other genes involved in flagellar and chemotaxis processes, qRT-PCR was
performed on key genes in each of these functional categories. No significant
modifications in transcript levels were seen for the majority of genes tested, except for
the flagellum-specific ATP synthase (fliI), flagellar motor switch protein (fliG2), and
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cheY3. All exhibited a 3-4 fold increase in transcription. Upregulation of CheY3 was
confirmed by immunoblots. These results indicate an accumulation of CheY3 is
occurring upon rrp1 deletion, but the constant run phenotype suggests the majority of
the CheY3 protein molecules remain in the dephosphorylated state, causing a
decreased affinity for the flagellar motor and reduced cellular ability to change flagellar
motor directional bias.
In E. coli, c-di-GMP has been demonstrated to influence protein-protein
interactions that control flagella motor rotation (23,62). The motility phenotype of B31Δrrp1 suggests that c-di-GMP may contribute to flagella motor activity in B. burgdorferi
as well. However, the wild type motility phenotype of the B31-OV strain, which would
be predicted to have elevated levels of c-di-GMP, seems at odds with the paradigm that
high levels of c-di-GMP inhibit motility and promote a sessile life style (34). Because
the diguanylate cyclase activity of Rrp1 is strictly dependent on its phosphorylation state
(27,77), elevated production of Rrp1 may not necessarily lead to an increase in c-diGMP. Rrp1 is cotranscribed with the histidine kinase, Hpk1, which is thought to serve
as its phosphate donor (70). Increased production of c-di-GMP may require elevated
production and autophosphorylation of Hpk1. The series of events required for this to
occur may be dependent on environmental stimuli which are unique to the tick-mammal
interface (70) and these stimuli may not be encountered during in vitro cultivation.
To determine if Rrp1 production levels correlate with c-di-GMP concentration, we
sought to measure the relative intracellular c-di-GMP concentration for each strain.
Nucleotide extracts were assayed using reverse phase-high performance liquid
chromatography. Precedent for the application of this highly sensitive approach comes
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from studies of c-di-GMP levels in E. coli (2). However, c-di-GMP levels in in vitro
cultivated B. burgdorferi proved to be below the detection threshold. This raises the
question: if the concentration of c-di-GMP is so low that it can’t be detected during in
vitro cultivation, is it even produced in vitro and is it plausible that the unique properties
of the B31-Δrrp1 strain are in fact due to the loss of diguanylate cyclase activity? The
recent demonstration that c-di-GMP pools are asymmetrical and localized within a cell
offers a possible explanation (20). It is possible that B. burgdorferi flagellar motor
function is controlled by a concentrated local pool of c-di-GMP that represents a small
fraction of the total cellular nucleotide pool. The deletion of rrp1 would eliminate this
pool and thus result in aberrant motility and chemotactic responses. Additional
evidence for c-di-GMP production by the Borrelia during in vitro growth has come from
the study of a B. hermsii pdeA deletion mutant. Deletion of pdeA, the primary
phosphodiesterase involved in c-di-GMP breakdown in the Borrelia, leads to the
accumulation of c-di-GMP thus allowing it to be detected by HPLC (R.T. Marconi,
unpublished results). While it would be informative to measure c-di-GMP levels in
spirochetes in vivo, such analyses are technically challenging due to the low numbers of
spirochetes in mammals and ticks. It may be possible in future analyses to employ
FRET based c-di-GMP biosensor approaches to assess changes in c-di-GMP levels in
response to environmental stimuli (20).

The role of PlzA and PlzB as c-di-GMP effectors and regulators of motility.
C-di-GMP signaling mediates a variety of processes necessary for altering
bacterial cellular lifestyles, as demonstrated by the Rrp1 data presented here along with
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a multitude of other studies (21,28,34,71). The regulatory effects of the c-di-GMP
system are instituted through c-di-GMP interaction with a variety of effector molecules
including GEMM riboswitches (87,95), PilZ domain-containing proteins (1,76),
ribonucleoprotein complexes (103), and cyclic monophosphate domains (35). To date,
only two proteins have been identified as effectors within B. burgdorferi, both of which
possess PilZ domains. The type strain of B. burgdorferi, strain B31, produces a single
chromosomally encoded c-di-GMP binding protein designated as PlzA (27). This
protein is necessary for murine infection and proper spirochete swarming, as shown by
this study and Pitzer et al (63). Interestingly, a second PilZ domain containing protein,
encoded by a variable linear plasmid, has been identified in some isolates. This protein
has been designated as PlzB. No functional analysis has ever been conducted to
understand the role of PlzB in B. burgdorferi pathogenesis.
In this study, we investigated if the c-di-GMP binding protein, PlzA, is important
to B. burgdorferi virulence and enzootic cycle progression of strain B31-5A4. Since this
clone does not contain PlzB, we additionally investigated if PlzB can functionally
complement PlzA in the infection cycle and particular cellular processes such as
motility, swarming, and NAG metabolism/chemotaxis. A strain lacking plzA (B31-ΔplzA)
and its complement (B31-plzA KI) were generated, along with a mutant possessing a
copy of plzB in the chromosomal location of plzA (B31-ΔplzA::plzB). Each stain was
tested for their ability to infect mice by subcutaneous inoculation. B31-wt and B31-plzA
KI were able to persist and disseminate, while B31-ΔplzA and B31-ΔplzA::plzB were
non-infectious. This result is typical of high c-di-GMP concentrations, indicating PlzA is
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necessary for proper c-di-GMP signaling for mammalian disease establishment but that
PlzB cannot be substituted for PlzA.
The lack of a murine infection would inhibit spirochete acquisition by natural tick
feeding; therefore, we tested if the strains were capable of tick colonization in a mouseindependent manner by immersion. All strains developed productive tick infections,
including B31-ΔplzA, demonstrating PlzA is only crucial for spirochete transmission to
murine hosts. Also this data suggests that PlzB, despite possessing the ability to bind
c-di-GMP in vitro, is not necessary for Borrelial enzootic cycle progression. Thus, PlzB
may be utilized for some other purpose besides virulence regulation or contribute to the
pathogenesis of specific B. burgdorferi strains.
Studies in other bacterial systems, as well as in B. burgdorferi, show motility is
correlated to c-di-GMP (37,96). The PilZ-containing c-di-GMP binding protein, YcgR, of
E. coli and Salmonella binds directly to the flagellar motor-switch complex proteins, FliG
and FliM, while in the presence of c-di-GMP to alter flagellar motor direction and speed
(62). Within B. burgdorferi, deletion of the diguanylate cyclase inhibits spirochete flexes
and locks the flagellar motors into a constant run, thus showing a role of c-di-GMP in
regulation of motor direction (41). To assess motility and basic motor function, the
strains were first evaluated in BSK-H media only. All strains retained proper wave
propagation and twitching, showing overall flagellar structure and function was not
altered. Next, translational motion was recorded by motion-tracking software in BSK-H
containing 1% methylcellulose for increased viscosity. Similar to the rrp1 deletion
mutant, B31-ΔplzA had a severe reduction in flexes and appeared locked in a constant
run. The most evident motility defect, however, was the dampening of average
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spirochete run speed. The B31-ΔplzA strain functioned at an average run speed
equivalent to 40% of the wild type. The B31-ΔplzA::plzB also exhibited these motility
defects, which further confirms the importance of PlzA in flagellar motor regulation and
demonstrates the inability of PlzB to functionally complement PlzA in these processes.
In contrast to YcgR of E. coli and Salmonella which is involved in a flagellar
backstop brake mechanism (62), this data indicates proper flagellar motor regulation
and speed is dependent upon PlzA, perhaps for torque generation and directional motor
changes. Borrelia possess a significantly more complicated flagellar and chemotaxis
signaling cascade than other bacterial systems. In particular, the motor switch contains
two FliG proteins (FliG1 and FliG2) instead of a singular FliG (26). FliG2 resembles a
component of the typical bacterial motor switch and is required for flagellation and
motility (47). FliG1 is only located at one of the flagellar motors and deletion mutants
remain motile, fail to translate in highly viscous media, and are quickly cleared during
murine infection. This strain phenotype resembles the B31-ΔplzA strain and implicates
a direct or indirect interaction between PlzA and FliG1, in addition to the possible
localization of PlzA to one pole to facilitate c-di-GMP control of flagellar motor bias.
It is likely that the influence of c-di-GMP on flagellar directional rotation could be
correlated with chemotaxis processes. Both PilZ domain-containing proteins and the
chemotaxis response regulator, CheY, have been shown to bind to the E. coli motor
switch to promote rotation bias (62,78), but it is unknown if cooperation exists between
the control mechanisms of these proteins. Microarray analysis, previously reported by
our lab, demonstrated Rrp1 and c-di-GMP positively regulate numerous motility and
chemotaxis genes (70). Therefore, we tested if PlzA and PlzB, as downstream c-di95

GMP effectors, could influence spirochete chemotaxis using swarming and capillary
chemotaxis assays. PlzA, not PlzB, was necessary for proper swarming; however, B31ΔplzA and B31-ΔplzA::plzB were not significantly defective in NAG chemotaxis. This
data indicates the reduced run speed could be directly impacting spirochete swarm
capabilities and mammalian infection ability. Although, a chemotaxis defect
independent of the NAG pathway could also be occurring. Transcription of the genes
involved in chitobiose and NAG metabolism was likewise unaffected by the various
genetic manipulations of PlzA, as shown by qRT-PCR. This confirms PlzA is not
important for the key NAG metabolic process required for survival within ticks and
correlates with the host infection and NAG chemotaxis pattern of the constitutive rrp1
mutant.
Overall, this PlzA study supports the existence of other c-di-GMP effectors in B.
burgdorferi. The swarming abilities of both the rrp1 and plzA deletion mutants are
comparable, yet the distinct motility phenotype and NAG chemotaxis response of each
strain highlights the obvious differences in the regulatory abilities of each gene. If PlzA
was the sole downstream c-di-GMP effector, the B31-ΔplzA strain would be expected to
exhibit characteristics like the rrp1 deletion or constitutive strain, thus being utilized for
the functional output associated with high or low intracellular c-di-GMP levels.
However, this is clearly not seen by all experiments in this study. The data
demonstrates that the c-di-GMP signaling cascade in Borrelia is much more complex
than just these two proteins. PlzA does appear to be a downstream effector in virulence
and swarming mechanisms. Although, it is likely that other effectors are utilized as well,
specifically for NAG chemotaxis and metabolism. Rrp1 could also be functioning
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independently to regulate NAG, since PlzA status does not impact these processes.
Studies of Rrp1 and PlzA are both critical to understanding Lyme spirochete
pathogenesis, but identification of other molecules involved in this signaling network is
necessary to solve the puzzle of this complicated signaling scheme.

PdeB, c-di-GMP, and the Lyme enzootic cycle.
The balancing of Borrelial intracellular c-di-GMP levels is maintained by
hydrolysis activities of phosphodiesterases (96,97) These proteins typically contain
either an EAL or HD-GYP domain to degrade the dinucleotide to pGpG or GMP
(34,81,98). The B. burgdorferi genome encodes two chromosomally encoded
phosphodiesterases, each protein harboring an EAL (PdeA) or HD-GYP domain (PdeB)
(70,96,97). PdeA is necessary for pathogen virulence in mammals (97) and deletion
mimics the constitutive rrp1 conditions, and by extension high c-di-GMP, demonstrating
that Rrp1 and PdeA must operate in a cooperative manner to balance c-di-GMP for
retention of strain pathogenicity. However, little is known about HD-GYP proteins within
bacterial systems in general. Since B. burgdorferi PdeA was critical for murine
infection, we hypothesized that inactivation of pdeB would provide a similar phenotype.
In addition, we believed the phosphodiesterases may act in a cooperative manner to
accomplish c-di-GMP degradation, perhaps by causing localized hydrolysis within
specific cellular compartments or by sequentially breaking the phosphodiester bonds of
the dinucleotide.
To determine if the role of PdeB in the enzootic cycle progression of B.
burgdorferi, pdeB was replaced with a spectinomycin/streptomycin resistance cassette
97

within the chromosome by allelic exchange mutagenesis to produce the deletion strain
B31-ΔpdeB. Expression of the phosphodiesterase was restored by ciscomplementation at the chromosomal location of pdeB to generate B31-pdeB KI. Both
strains were evaluated for mammalian infection capabilities by subcutaneous
inoculation of C3H-HeJ mice. Unlike PdeA, PdeB was not required for mammalian
disease and all strains established a productive infection.
Spirochete passage to Ixodes ticks was analyzed to determine if loss of pdeB
expression resulted in defective pathogen uptake. Naïve ticks were fed until repletion
on needle inoculated mice four weeks post-infection. qPCR revealed all mutants were
acquired by the Ixodes ticks, yet the B31-ΔpdeB strain displayed a decreased efficiency
in colonization. To validate the natural feeding results and assess if PdeB functions
mainly in the tick to mouse transmission, ticks were infected via immersion methods and
fed on naïve mice. The decreased tick colonization of the pdeB deletion strain in
comparison to the wild type and complemented strains was also shown using this
technique. This deficiency could make the spirochetes less suitable for survival within
the tick environment and there is evidence that loss of pdeB results in spirochete killing
post-tick engorgement (96) rather than during the blood meal, as occurs with cells
lacking rrp1/hpk1 (33). Additionally, the B31-ΔpdeB strain was not transmitted to
uninfected murine hosts by tick bite, demonstrating PdeB is essential for proper
regulation of tick factors critical for transmission. PdeB could be necessary for
modification of gene expression of genes differentially expressed between tick and
murine environments, thus preventing transfer to and/or survival within the mammalian
host. Together, this data supports the idea of tightly controlled regulation of intracellular
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c-di-GMP levels in Borrelia burgdorferi for all phases of the pathogen’s enzootic cycle
and that each gene of the c-di-GMP signaling network is required for full virulence in
both the mammalian host and tick vector.
Uniquely, PdeA and PdeB both abrogate murine infection; however these defects
are distinctive from one another. PdeA is a critical factor within the mammal since it is
able to effectively colonize ticks and both tick feeding as well as needle inoculation are
unable to initiate mammalian disease. PdeB is only necessary for pathogen
transmission by tick bite, identifying the gene as a key factor only within the tick. This
distinguishing difference in virulence patterns between the PdeA and PdeB suggests
each phosphodiesterase possesses a unique niche in Borrelial pathogenesis rather
than working in concert to accomplish the same task.
Deletion of pdeB also results in a distinct motility and morphological phenotype.
Cells were locked in constant state of flexing which prevented translational motion in
highly viscous media (BSK-H + 1% methylcellulose), disrupted flagellar wave
propagation, and reduced swarming. The constant flex state has also been described
in a mutant possessing a cheX deletion (CheY phosphatase) (56), which suggests PdeB
could be involved in chemotaxis processes like Rrp1. Although, PdeB was not found to
be necessary for NAG chemotaxis in this work, the phosphodiesterase may be involved
in chemotaxis towards other molecules. A recent study by Sultan et al, demonstrated a
mutant containing deletions of pdeB and plzA also resulted in the same constant flexing
phenotype (96), while inactivation of plzA alone caused constant running, reduced
flexing, and slower run speeds. This indicates PdeB may alter c-di-GMP intracellular
concentrations to cause PlzA-independent modification of CheX or CheY3 to change
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flagellar rotational bias. However, PlzA may still be involved in motor directional change
through the control of PdeA since inactivation of plzA resulted in a constant run
phenotype equivalent to that of the pdeA deletion mutant.
In summary, this study demonstrates that Rrp1, PlzA, and PdeB regulate stage
specific steps in the enzootic cycle of Lyme disease spirochetes. Deletion of rrp1
prevented the establishment of a productive population in ticks, while elevated
production blocked infectivity in mice. Disruption of plzA inhibited murine infection but
did not alter tick colonization. Lastly, PdeB was identified as a tick-specific factor which
is necessary for tick to mouse transmission via natural infection methods. Each
component was found to be intricately linked to flagellar motor regulation and perhaps
through chemotactic responses, processes which are likely to be critical for completion
of the enzootic cycle. Since diguanylate cyclase and phosphodiesterase activity is the
only known function of Rrp1 and PdeB, respectively, it is highly probable that c-di-GMP
levels are responsible for the phenotypes observed for the strains generated in this
report. In constructing future models for Borrelia pathogenesis, genetic regulation and
motility, it will be important to consider the far reaching regulatory potential of c-di-GMP.
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CHAPTER 5: PERSPECTIVES

In bacterial pathogenesis, c-di-GMP has emerged as an important modulator of
virulence and pathogen lifestyle by regulation of motility state, biofilm formation, etc
(98). The molecule maintains its versatility and ability to rapidly influence many
processes through the integration of various classes of effectors (34). Until recently, the
multiplicity of diguanylate cyclase, phosphodiesterase, and c-di-GMP effector domains
has greatly impeded understanding the full biological implication of this signaling
mechanism. The field of c-di-GMP regulation is now in a time of great expansion.
Cutting edge studies have demonstrated the spatial localization of c-di-GMP during
cellular division of various gram negative bacteria and allowed for imaging of c-di-GMP
binding within live cells using advanced intracellular fluorescent resonance energy
transfer techniques (FRET) (20). Additionally, a unique and simplified model has been
identified within Lyme disease spirochetes, in particular Borrelia burgdorferi, which is
ideal to investigate the specific functions of each component of the c-di-GMP network
and characterize this type of signaling in arthropod-borne pathogens
(27,41,63,70,96,97).
Throughout the course of this dissertation, the Borrelia burgdorferi c-di-GMP
network components have been shown to be major regulators of Lyme pathogenesis.
This work specifically highlights the coordination of motility and chemotaxis processes
with cellular virulence and enzootic cycle completion, signifying the integration of c-di101

GMP control into the global regulatory networks of Borrelia. It is not yet known if
intracellular c-di-GMP levels produce the virulence, motility, and chemotaxis phenotypes
or if the changes are independent of c-di-GMP. However, since similar phenotypes are
exhibited between select mutants, it is likely that the recorded changes and enzootic
cycle disruption are directly correlated with cellular c-di-GMP fluctuations.
Collectively, these analyses also present a distinct paradigm shift in the overall
association of c-di-GMP levels with specific phenotypes. High c-di-GMP concentrations
are generally thought to inhibit virulence and motility by promoting sessility and biofilm
formation, while low levels would enhance cell mobility and infection capability within
gram negative pathogens. However, Borrelia burgdorferi spirochetes are quite
divergent from these bacterial systems, do not produce biofilms, and possess an
enzootic cycle requiring both passage and colonization of various hosts. The data
presented here suggests c-di-GMP signaling in Borrelia is employed for environmental
adaption to the vector and mammalian host rather than for an individual host or hostindependent conditions, as displayed with Vibrio and Bordetella (71). In theoretically
high intracellular c-di-GMP conditions (constitutive Rrp1 or inactivated PdeA),
spirochetes are unable to establish a productive mammalian infection (41,97), while low
c-di-GMP levels (deletion of rrp1) block spirochete acquisition by ticks, thus implicating
enzootic cycle completion requires fine-tuned regulation and maintenance of a specific
intracellular c-di-GMP concentration (Figure 5-1).
Overall, the use of c-di-GMP as a secondary messenger is a rapid and efficient
signal transduction method which is vital to bacterial pathogenesis. The identification
and characterization of c-di-GMP regulation in Borrelia represents an important step
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X

high c-di-GMP

low c-di-GMP

X
Acquisition
Figure 5-1. Putative c-di-GMP regulatory concepts of the Borrelia burgdorferi
enzootic cycle.
Successful spirochete transmission and acquisition requires
maintenance of a specific intracellular c-di-GMP concentration. Deletion of rrp1, the sole
diguanylate cyclase, inhibits pathogen transfer from infected mammals to feeding Ixodes
ticks by theoretically abrogating c-di-GMP synthesis. Conversely, inactivation of the PdeB
phosphodiesterase and/or constitutive expression of the diguanylate cyclase abolishes
Lyme disease establishment within murine hosts by promoting c-di-GMP accumulation.
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forward in the comprehension of pathogenic mechanisms of bacteria in general, as well
as Lyme spirochetes and other arthropod-borne pathogens. C-di-GMP signaling
additionally represents a new target for the development of Lyme disease therapeutics.
Enhanced knowledge of Borrelia burgdorferi c-di-GMP processes is necessary to further
understand specific molecular interactions and the complex functional output of this
system for innovative drug design and advanced preventative strategies.

Future analyses
Despite the progress in Borrelial c-di-GMP research, many important questions
remain unanswered. The intracellular concentrations are not yet known and
measurement is limited by the sensitivity of current quantitation methods, preventing
assessment of c-di-GMP concentrations upon diguanylate cyclase and
phosphodiesterase genetic manipulation. It is also unknown if this measurement
limitation is due to the instrumentation, if the dinucleotide merely exists in low levels in
Borrelia, and/or if c-di-GMP is only present in specific cellular compartments. Recently,
studies have revealed that c-di-GMP is asymmetrically distributed between mother and
daughter cells during cell division of Caulobacter and Pseudomonas (20). It is also
generally believed that the functional redundancy of c-di-GMP networks suggest
localized subcellular pools of the dinucleotide exist within cells (34). Since c-di-GMP
signaling in Borrelia impacts flagellar motor regulation, it is possible that c-di-GMP
concentrations are tightly regulated at the poles in order to control motor directional
bias. Current efforts are underway to characterize intracellular levels and the spatial
localization of c-di-GMP within B. burgdorferi via an alternative method to HPLC. FRET
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analysis will be employed to determine cellular concentrations and identify where c-diGMP is located within the organism using a verified E. coli and Salmonella biosensor,
YcgR (kindly shared by Dr. Samuel I. Miller) (20). Likewise, this method will be used to
distinguish if c-di-GMP binds PlzA and to detect if these protein-dinucleotide interactions
are targeted to the cellular poles and flagellar motors. These analyses will provide
direct evidence that c-di-GMP signaling does occur within the pathogen and pinpoint the
spatial orientation of PilZ domain interactions with c-di-GMP.
The molecular mechanisms by which c-di-GMP exerts its effects is still unknown.
PilZ domain-containing proteins are currently the only effector molecule type known to
exist within Borrelia, however it is highly probable that other c-di-GMP effectors are
present. The lack of identification may be due to the use of improper parameters for
bioinformatic detection of other effectors in B. burgdorferi, the dissimilarity between
Borrelial effectors and those of gram negative pathogens, etc. Furthermore, there also
is a possibility that the identified c-di-GMP effectors, PlzA and PlzB, could possess
functions independent of c-di-GMP signaling. Until clarity is achieved with the state of
other effectors, we will aim to focus our studies to the PilZ domain-containing proteins to
identify targets for c-di-GMP regulation, specifically. Pulldown assays will be performed
and coupled with mass spectrometry to detect key protein-protein interactions with PlzA
and PlzB in the presence of c-di-GMP. This data would aim to provide the first example
of specific molecular interactions which are dependent upon c-di-GMP.
PilZ-containing proteins have been shown to bind the flagellar motor switch (62),
therefore PlzA green fluorescent protein (GFP) and FliG1 red fluorescent protein
(mRFP) fusions will be constructed and then co-transformed to characterize the spatial
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orientation of each protein in relation to one another within B. burgdorferi pathogenic
strain B31-5A4. Deletion mutants of plzA and fliG1 both exhibited similar motility,
swarming, and virulence phenotypes, thus it is hypothesized that PlzA and FliG1 may
work in cooperation or interact to control these processes and motor rotational control.
Data demonstrating co-localization would provide evidence of the unique ability of PlzA
to localize to the specific location of FliG1, thus suggesting PlzA may possess the ability
to regulate FliG1 function and thereby alter spirochete motility.
C-di-GMP has been also linked to Borrelial chemotaxis processes, yet this
mechanism is still uncharacterized and the degree of crosstalk between the Rrp1-Hpk1
and chemotaxis TCS is unknown. To further understand the method of chemotaxis
control by c-di-GMP, multiple approaches will be utilized. First, the role of Rrp1 and
PlzA in CheY3 regulation and phosphorylation state will be investigated. A CheY3 sitedirected mutant deficient in phosphorylation will be generated to assess the motility and
chemotaxis patterns associated with CheY3 in its dephosphorylated state and compare
phenotypes with the rrp1 and plzA deletion strains. If phenotypes exhibited by deletion
of rrp1 and the site-directed cheY3 mutants are comparable, studies will be performed
to determine if these proteins interact and bind the flagellar motor to cause these motor
bias phenotypes. The results could potentially represent the first identified c-di-GMP
signaling cascade in Borrelia which impacts the chemotaxis TCS, further demonstrating
the far-reaching global regulatory ability of c-di-GMP.
In summary, it is evident that c-di-GMP is a major regulator of the Lyme enzootic
cycle, yet characterization has truly just begun and c-di-GMP signaling in Borrelia still
remains in its infancy. These analyses represent the next generation in spirochete c-di106

GMP research by focusing on the identification of specific molecular interactions and
understanding the expansive scope c-di-GMP regulation. Targeting c-di-GMP signaling
mechanisms holds great promise for the development of countermeasures to combat
the increasingly persistent and emerging infection, Lyme disease.
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APPENDIX A

Oligonucleotides used in this study.
Oligonucleotide

Sequence (5'➝3')

General primers
KOverifyUp F (1)

CTTTAATGGGGCTTGGTATATGC

KOverifyDwn R (2)

GTTGATGCATCTGTTAAAATTG

Aad1-5'-R (3)

TCCTTGAAGCTCGGGTATTA

pKFSS1-3'F (4)

GGCGAGATCACCAAGGTAGTC

Kan-5'-R (5)

CAGCATCCATGTTGGAATTTAATCGC

Kan-3'-F (6)

GATATGAATAAATTGCAGTTTCATTTG

Kan pBSV2 F (7)

GCGATTAAATTCCAACATGGATGCTG

Kan pBSV2 R (8)

ACTCATCGAGCATCAAATGAAACTGC

FlaB F

CAGGTAACGGCACATATTCAGATGC

FlaB R

CTTGGTTTGCTCCAACATGAACTC

BB0419F_LIC

GACGACGACAAGATGGAAATGATAATTAAAGATAAAGC

BB0419R_LIC

GAGGAGAAGCCCGGTTTAATATCTAAACTGATTTCTTCCAG

BB0733F_LIC

GACGACGACAAGATTTTGTTTAGTATTTTTATATTCAAAAAAA
GGAGAAAG

BB0733R_LIC

GAGGAGAAGCCCGGTTTAATTGAAATAATCATGGATCAACAT
AGATAC

BB0733 KO >1kb upstr F (9)

GCTATCATTGCTCCTTCAGGCTGTGC

BB0733 KO >1kb downstr R (10)

CCTTTAATAGTACATGTTGATACGG

BB0374 F

AATTAGCTCTATTTCATTTTG

BB0374 R

ATGCAAAATTCTGAAAGCATTA

BB0374 KO >1kb upstr F (11)

GGACTAATGTCTTTATTCGCCCATGT

BB0374 KO >1kb downstr (12)

CCAAATATTATTCCCTGATCCCCTGCT

B31-rrp1 KI construction
BB0419F-1kb-upstr

GCCCATTAATGTTTTAATAGCTGA

119

Rev_419+AatII+AscI

GGCGCGCCTAGGACGTCTTAATATCTAAACTGATTTCTTCCA
GAAAC

Fwd_KanR+1kbDNST419

GAGTTTTTCTAAATTTATATTTAATAGACTTTAGTATTTATAAG
TTATAGACATTCC

Rev_1kbDNST419+AscI

GGCGCGCCCTTTCCCAAGATCAACAGAACTTAG

Fwd_KanR+AatII

GACGTCCTTTAATAAAACAATATGTTGCGATGATTAAGG

Rev_KanR+1kbDNST419

CTTATAAATACTAAAGTCTATTAAATATAAATTTAGAAAAACT
CATCGAGCATCAAATG

B31-rrp1 OV construction
pFlaB+BamHI F

GTGGATCCTGAACTTAATACCTTGG

pFlaB+ClaI+SalI R

GTCGACATAATCGATTCCTCCATGATAAAATTTAAATTTC

419+ClaI F

ATCGATAATGATAATTAAAGATAAAGCTTTTG

419+SalI R

GTCGACCGCTTAATATCTAAACTGATTTCTTCC

B31-ΔplzA construction
BB0733KO-UP F

CATTTGATACAACTTGGTTTAAAACTG

BB0733KO-UP R

ACCGGTCTAGACGTCAGCTTCAAATTGTTTTAAACAGTTTTA
C

BB0733KO-DN F

GACGTCTCAAAGGATTGAAATTTTTCTTATGTGATTATG

BB0733KO-DN R

ACCGGTCAGAATATATTCCCAAAAGTGCCC

Spec/strep F

TGATTTGCTGGTTACGGTGA

Spec/strep R

ATTTGCCGACTACCTTGGTG

B31-plzA KI construction
BB0733 KI F

GACGTCTTGTTTAGTATTTTTATATTCAAAAAAAGGAGAAAG

BB0733 KI R

CCTTGAAGCTCGGGTATTAGTTAATTGAAATAATCATGGATC
AACATAGTATAC

PflgB-aphI-t7 (BB0733) KI F

GTATACTATGTTTAGCCATGATTATTTCAATTAACTAATACCC
GAGCTTCAAGG

PflgB-aphI-T7 KI R

GACGTCCAGATCCGGATATAGTTCCTCCTTTC

B31-ΔplzA::plzB construction
PlzB KI-UP F

CATTTGATACAACTTGGTTTAAAACTG

PlzB KI-UP R

TATCACACCGGTGACGTCAAACCTCTCCTTTCTCCTTTTTTT
G

PlzB KI F

GACGTCATGGCAGTATCATCTAAAAAGATAAGAGAG

PlzB KI R

TAATTATG

CTTCCTTGAAGCTCGGGTAGTCAGTCTTCAAAAAAATTAAAA

120

Kan KI F

TATCACCCCGGGCTAATACCCGAGCTTCAAGGAAGA

Kan KI R

TATCACGACGTCTTAGAAAAACTCATCGAGCATCAAATGAAA
C

B31-ΔpdeB construction
BB0374KO-UP

CCGCAAGACTTTGCAAAAAAATAATTAAAC

BB0374KO-UP R

ACCGGTCTAGACGTCTTATTCCCTTGAAATTAAGCTCTATTA
AC

BB0374KO-DN F

GACGTCAGACACTTAAAAGGAGAAAAAATATGATTTTG

BB0374KO-DN R

ACCGGTGTTATTGTTTTGTAATCAAGCCCATAATC

Spec/strep F

TGATTTGCTGGTTACGGTGA

Spec/strep R

ATTTGCCGACTACCTTGGTG

B31-pdeB KI construction
BB0374 KI F

GACGTCATGAAAAATCCAAATGCAATTG

BB0374 KI R

GATTTTACATCAGTTTGATTTATAAGATCAACGCTAGCTTAAA
TAGGTTCTGGTTTATGC

PflgB-Kan(BB0374) KI Fwd

GAAATAGAGCTAATTAAAAATAAATATTCTTTAATAGATATTA
TATAACTAATACCCGAGCTTCAAGG

PflgB-aphI-T7 KI R

GACGTCCAGATCCGGATATAGTTCCTCCTTTC

Tick qPCR
FlaB BB0147F-RT

CAGGTAACGGCACATATTCAGATGC

FlaB BB0147R-RT

CTTGGTTTGCTCCAACATGAACTC

Tick RIB-3 (ITS2)

CGGGATCCTTC(A,G)CTCGCCG(C,T)TACT

Tick RIB-4 (ITS2)

CCATCGATGTGAA(C,T)TGCAGGACA

RT-PCR
Rrp1 BB0419F-RT

TTGAGGTTGCAACAAATGGA

Rrp1 BB0419R-RT

CGGGATCGCTTTTTAGCTTT

Eno BB0337F-RT

GCTTGAACTTGATGGCACCCCTAC

Eno BB0337R-RT

GTACGCTCCAAGATATTGATAAGG

BB0002F-RT

GCGGAGCAGACAAAGGGATTGATT

BB0002R-RT

ACATGCTCCATGGCCGGAAA

NagA BB0151F-RT

GCAGCTGGTGGAGTATTTACAGGA

NagA BB0151R-RT

GTGTGTCCCGCTTGAAGGTTTATG

NagB BB0152F-RT

GGGCGGCTAATCATGTAGCACAAA

NagB BB0152R-RT

CAATCGGAGAGCTTCCTGTTGGA
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PtsG BB0645F-RT

AGAACTTGCTGCCCAAGGTACAGA

PtsG BB0645R-RT

CCGGGCAAACCAAACATCATGGTA

FliD BB0149F-RT

GTCAGGAAATTCTAGTAATAGCGAAG

FliD BB0149R-RT

CTTTCTTGCCAACTAAAAATATATAATCTCC

put fla BB0180F-RT

GAAATAGGACTTAAAGAGGTCGC

put fla BB0180R-RT

CCAATTTTCAATTTGTGTAGATAGTCG

FlgL BB0182F-RT

GAGCAAGCGGAACTTATGAATC

FlgL BB0182R-RT

CGCACCGTCTTTGCTTGTTTTGC

FliG-1 BB0221F-RT

GCAAAGAGAGTAAGGTCACAAAG

FliG-1 BB0221R-RT

CTTAGTAACTCTTCAAATTCTTTAATAATATGC

FlgD BB0284F-RT

GGTTAATCTTGGCAAGGATG

FlgD BB0284R-RT

GATGAAAGTTTTTCAAACGATCTACTC

FliI BB0288F-RT

GGTATGCGCAGAGGTTTTAG

FliI BB0288R-RT

CCTTTATTATCAATAGGTCTGCCAAG

FliF BB0291F-RT

CTTGTCAGAGAAGAGCTTGTG

FliF BB0291R-RT

GGCATAACAAGATTCACACTAACAG

FliE BB0292F-RT

CGATTACTGATGTCAACAAAAGCC

FliE BB0292R-RT

CTTGATAAGCCTTCACACCTC

FlgB BB0294F-RT

CTTAATTAAATCTAGTGATAAGCACCTG

FlgB BB0294R-RT

GTTTTGCACAAGTGCCTTAAC

CheW-2 BB0565F-RT

GTCAGTATCTTTTATTTAGTTTGGACG

CheW-2 BB0565R-RT

GAATATCAATTATTGGAACGATTTTGCC

CheA1 BB0567F-RT

GAGAGCTTATTGAAGGCGATGAAG

CheA1 BB0567R-RT

CTTTAACAGACTCTTCCAAAACCGAAC

CheY2 BB0570F-RT

GGAGTCTCAGAAGCAAAAGATGG

CheY2 BB0570R-RT

GATTGCTCAGATTCAGTGGTAAGAAC

Mcp-2 BB0596F-RT

CGACTAGGTACGACTATCGGTC

Mcp-2 BB0596R-RT

GCCCAATAGCAATTCTTTTAAACTTATG

Mcp-3 BB0597F-RT

GAGATAGCTATAGGTTTGGGATATTG

Mcp-3 BB0597R-RT

CCTTCAAGTGAATCTTCTGCTAAAG

CheX BB0671F-RT

CGGGCTTAAGTCGATAAATCAAAAG

CheX BB0671R-RT

CAGCAACCATCTCTTTTGTTTCTTC

CheY3 BB0672F-RT

GTTGATGACTCTGTTTTTACCGTAAAG

CheY3 BB0672R-RT

GACAAGTTATTCCATCCATTTTGG

Mcp-4 BB0680F-RT

GCTGTTGAGGATTATAGGCAAAAC
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Mcp-4 BB0680R-RT

GCAAATATCCGGCCAAATACC

Mcp-5 BB0681F-RT

CTACGGCGGTTAAGGATAATAGTG

Mcp-5 BB0681R-RT

GGCATACCTATTAATATGTAAGGAATCTG

PlzA BB0733F-RT

CTGATAAAGCTTTTATCAAGTTTAATGGAG

PlzA BB0733R-RT

AGCGCAAAAACCTTTCCGCT

PlzB BBU_ZS7F20F-RT

TAGTATACTCAAGCGGGATATTACTC

PlzB BBU_ZS7F20R-RT

GGAATCCTTGATGAAGACATGG

PdeB BB0374F-RT

ATCTAGACGGAACTGGCTATCCT

PdeB BB0374R-RT

ATAGCAGAATAGGCACTAGCAGCG

pMAL-c4x constructs
BB0419pMAL-BamHIF

CGGATCCGTGGAAATGATAATTAAAGATAAA

BB0419pMAL-SalIR

CCCGTCGACTTAATATCTAAACTGATTTCTTCC

BB0733pMAL-BamHIF

GGATCCTTGTTTAGTATTTTTATATTCAAAAAAAGGAGAAAG
GAGAGGT

BB0733pMAL-SalIR

GTCGACTTAATTGAAATAATCATGGATCAACATAGTATACTC
AAGTGGTA

PlzB pMAL-BamHIF

GGATCCATGGCAGTATCATCTAAAAAGATAAGAGAGTATAGA
AA

PlzB pMAL-SalIR

GTCGACTCAGTCTTCAAAAAAATTAAAATAATTATGGATTATC
ATAGTATACTCAA

WspR pTYB12 vector
WspRpTyb12-BsmIF

GAATGCTATGCACAACCCTCATGAGAGCAAG

WspRpTyb12-EcoRIR

GAATTCTCAGCCCGCCGGGGCCGG
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